Attribute,Description,Valid Values,Requires,Properties,Required,Parent,Requires Component,Source,Validation Rules
Assay,"A planned process with the objective to produce information about the material entity that is the evaluant, by physically examining it or its proxies.[OBI_0000070]",,,,FALSE,,,http://purl.obolibrary.org/obo/OBI_0000070,
Device,"A thing made or adapted for a particular purpose, especially a piece of mechanical or electronic equipment""",,,,FALSE,Assay,,https://w3id.org/biolink/vocab/Device,
Sequencing,Module for next generation sequencing assays,,,,FALSE,Assay,,http://example.org/htan/Sequencing,
Component,"Category of metadata (e.g. Diagnosis, Biospecimen, scRNA-seq Level 1, etc.); provide the same one for all items/rows.",,,,TRUE,,,https://w3id.org/biolink/vocab/category,
Patient,HTAN patient,,"Component, HTAN Participant ID",,FALSE,Individual Organism,"Demographics, Family History, Exposure, Follow Up, Diagnosis, Therapy",http://example.org/htan/Patient,
File,A type of Information Content Entity specific to OS,,,"Filename, File Format",FALSE,Information Content Entity,,https://w3id.org/biolink/vocab/DataFile,
Filename,Name of a file ,,,,TRUE,,,http://example.org/htan/filename,
File Format,"Format of a file (e.g. txt, csv, fastq, bam, etc.)",,,,TRUE,,,http://example.org/htan/fileFormat,
HTAN Data File ID,self-dentifier for this data file - HTAN ID of this file HTAN ID SOP (eg HTANx_yyy_zzz),,,,TRUE,File,,https://docs.google.com/document/d/1podtPP8L1UNvVxx9_c_szlDcU1f8n7bige6XA_GoRVM/edit?usp=sharing,
HTAN Participant ID,HTAN ID associated with a patient based on HTAN ID SOP (eg HTANx_yyy ),,,,TRUE,Patient,,https://docs.google.com/document/d/1podtPP8L1UNvVxx9_c_szlDcU1f8n7bige6XA_GoRVM/edit?usp=sharing,
HTAN Biospecimen ID,HTAN ID associated with a biosample based on HTAN ID SOP (eg HTANx_yyy_zzz),,,,TRUE,Biospecimen,,https://docs.google.com/document/d/1podtPP8L1UNvVxx9_c_szlDcU1f8n7bige6XA_GoRVM/edit?usp=sharing,
HTAN Parent ID,HTAN ID of parent from which the biospecimen was obtained. Parent could be another biospecimen or a research participant.,,,,TRUE,Biospecimen,,https://docs.google.com/document/d/1podtPP8L1UNvVxx9_c_szlDcU1f8n7bige6XA_GoRVM/edit?usp=sharing,
HTAN Parent Biospecimen ID,HTAN Biospecimen Identifier indicating the biospecimen(s) from which these files were derived,,,,TRUE,Biospecimen,,https://docs.google.com/document/d/1podtPP8L1UNvVxx9_c_szlDcU1f8n7bige6XA_GoRVM/edit?usp=sharing,
HTAN Parent Data File ID,HTAN Data File Identifier indicating the file(s) from which these files were derived,,,,TRUE,File,,,
Demographics,Individual biomedical demographics attributes,,"Component, HTAN Participant ID, Ethnicity, Gender, Race, Vital Status, Days to Birth, Age Is Obfuscated, Year Of Birth, Occupation Duration Years, Premature At Birth, Weeks Gestation at Birth",,FALSE,Patient,,,
Family History,Individual's family cancer history,,"Component, HTAN Participant ID, Relative with Cancer History",,FALSE,Patient,,,
Exposure,Individual's exposure to carcenogens,,"Component, HTAN Participant ID, Smoking Exposure, Asbestos Exposure, Coal Dust Exposure, Environmental Tobacco Smoke Exposure, Radon Exposure, Respirable Crystalline Silica Exposure",,FALSE,Patient,,,
Follow Up,Individual's follow up exams,,"Component, HTAN Participant ID, Days to Follow Up, Adverse Event, Progression or Recurrence, Barretts Esophagus Goblet Cells Present, BMI, Cause of Response, Comorbidity, Comorbidity Method of Diagnosis, Days to Adverse Event, Days to Comorbidity, Diabetes Treatment Type, Disease Response, DLCO Ref Predictive Percent, ECOG Performance Status, FEV1 FVC Post Bronch Percent, FEV 1 FVC Pre Bronch Percent, FEV1 Ref Post Bronch Percent, FEV1 Ref Pre Bronch Percent, Height, Hepatitis Sustained Virological Response, HPV Positive Type, Karnofsky Performance Status, Menopause Status, Pancreatitis Onset Year,  Reflux Treatment Type, Risk Factor, Risk Factor Treatment, Viral Hepatitis Serologies, Weight",,FALSE,Patient,,,
Therapy,Individual's first line of therapy or treatment,,"Component, HTAN Participant ID, Treatment or Therapy, Treatment Type, Treatment Effect, Treatment Outcome, Days to Treatment End, Treatment Anatomic Site, Days to Treatment Start, Initial Disease Status, Regimen or Line of Therapy, Therapeutic Agents, Treatment Intent Type",,FALSE,Patient,,,
Diagnosis,Individual's diagnosis,,"Component, HTAN Participant ID, Age at Diagnosis, Year of Diagnosis, Primary Diagnosis, Site of Resection or Biopsy, Tissue or Organ of Origin, Morphology, Tumor Grade, Progression or Recurrence, Last Known Disease Status, Days to Last Follow up, Days to Last Known Disease Status,  Method of Diagnosis, Prior Malignancy, Prior Treatment, Metastasis at Diagnosis, Metastasis at Diagnosis Site, First Symptom Prior to Diagnosis, Days to Diagnosis, Percent Tumor Invasion, Residual Disease, Synchronous Malignancy, Tumor Confined to Organ of Origin, Tumor Focality, Tumor Largest Dimension Diameter, Gross Tumor Weight, Breslow Thickness, Vascular Invasion Present, Vascular Invasion Type, Anaplasia Present, Anaplasia Present Type, Laterality, Perineural Invasion Present, Lymphatic Invasion Present, Lymph Nodes Positive, Lymph Nodes Tested, Peritoneal Fluid Cytological Status, Classification of Tumor, Best Overall Response, Mitotic Count, AJCC Clinical M, AJCC Clinical N, AJCC Clinical Stage, AJCC Clinical T, AJCC Pathologic M, AJCC Pathologic N, AJCC Pathologic Stage, AJCC Pathologic T, AJCC Staging System Edition",,FALSE,Patient,,,
Biospecimen,"HTAN biological entity; this can be tissue, blood, analyte and subsamples of those",,"Component, HTAN Biospecimen ID, HTAN Parent ID, Timepoint Label, Collection Days from Index, Biospecimen Type, Acquisition Method Type, Fixative Type, Site of Resection or Biopsy, Storage Method, Processing Days from Index, Protocol ID, Site Data Source, Processing Location, Histology Assessment By, Histology, Assessment Medium, Tumor Infiltrating Lymphocites, Degree of Dysplasia, Dysplasia Fraction, Number Proliferating Cells, Percent Eosinophil Infiltration, Percent Granulocyte Infiltration, Percent Inflam Infiltration, Percent Lymphocyte Infiltration, Percent Monocyte Infiltration, Percent Necrosis, Percent Neutrophil Infiltration, Percent Normal Cells, Percent, Stromal Cells, Percent Tumor Cells, Percent Tumor Nuclei, Fiducial Marker, Slicing Method, Antigen Retrieval, Biospecimen Slide Location, Staining Markers, Lysis Buffer, Method of Nucleic Acid Isolation",,FALSE,Biosample,Patient,http://example.org/htan/Biospecimen,
Other Assay,Metadata applying to any assay without standard descriptors. Can be used as a placeholder for minimal amount of metadata until the assay descriptors are standardized,,"Component, Filename, File Format, HTAN Parent Biospecimen ID, HTAN Data File ID, Assay Type",,FALSE,Assay,Biospecimen,,
Assay Type,"The type and level of assay this metadata applies to (e.g. RPPA, Nanostring DSP, etc.)",,,,TRUE,Assay,,,
scRNA-seq Level 1,Single-cell RNA-seq [EFO_0008913],,"Component, Filename, File Format, HTAN Parent Biospecimen ID, HTAN Data File ID, Nucleic Acid Source, Cryopreserved Cells in Sample, Single Cell Isolation Method, Dissociation Method, Library Construction Method, Read1, Read2, End Bias, Reverse Transcription Primer, Spike In, Sequencing Platform, Total Number of Input Cells, Input Cells and Nuclei, Library Preparation Date, Single Cell Dissociation Date, Sequencing Library Construction Date, Nucleic Acid Capture Date, Protocol Link, Technical Replicate Group",,FALSE,Sequencing,Biospecimen,http://www.ebi.ac.uk/efo/EFO_0008913,
scRNA-seq Level 2,QC pipelines downstream of scRNA-seq Level 1,,"Component, Median Number of Reads or UMIs per Cell, Median Number Genes per Cell, Total Number of Cells",,FALSE,Sequencing,scRNA-seq Level 1,,
Bulk RNA-seq Level 1,Bulk RNA-seq [EFO_0003738],,"Component, Filename, File Format, HTAN Parent Biospecimen ID, HTAN Data File ID, Library Layout, Nucleic Acid Source, Sequencing Platform, Sequencing Batch ID, Read Length, Library Selection Method, Library Preparation Kit Name, Library Preparation Kit Vendor, Library Preparation Kit Version, Library Preparation Date, Spike In, Adapter Name, Adapter Sequence, Base Caller Name, Base Caller Version, Flow, Cell Barcode, Fragment Maximum Length, Fragment Mean Length, Fragment Minimum Length, Fragment Standard Deviation Length, Lane Number, Library Strand, Multiplex Barcode, Size Selection Range, Target Depth, To Trim Adapter Sequence, Transcript Integrity Number (TIN), RIN, DV200, Adapter Content, Basic Statistics, Encoding, Kmer Content, Overrepresented Sequences, Per Base N Content, Per Base Sequence Content, Per Base Sequence Quality, Per Sequence GC Content, Per Sequence Quality Score, Per Tile Sequence Quality, Percent GC Content, Sequence Duplication Levels, Sequence Length Distribution, Total Reads, QC Workflow Type, QC Workflow Version, QC Workflow Link ",,FALSE,Sequencing,Biospecimen,http://www.ebi.ac.uk/efo/EFO_0003738,
Bulk RNA-seq Level 2,Bulk RNA-seq alignment protocol description,,"Component, Filename, File Format, HTAN Parent Biospecimen ID, HTAN Data File ID, HTAN Parent Data File ID, Alignment Workflow Url, Alignment Workflow Type, Genomic Reference, Genomic Reference URL, Index File Name, Average Base Quality, Average Insert Size, Average Read Length, Contamination, Contamination Error, Mean Coverage, MSI Workflow Name/URL, MSI Score, MSI Status, Pairs On Diff CHR, Total Reads, Total Uniquely Mapped, Total Unmapped reads, Proportion Reads Duplicated, Proportion Reads Mapped, Proportion, Targets No Coverage, Proportion Base Mismatch, Short Reads",,FALSE,Sequencing,,,
Nucleic Acid Source,The source of the input nucleic molecule,"Single Cell, Bulk Whole Cell, Single Nucleus, Bulk Nuclei",,,TRUE,Sequencing,,http://example.org/htan/NucleicAcidSource,
Single Cell Isolation Method,"The method by which cells are isolated into individual reaction containers at a single cell resolution (e.g. wells, micro-droplets)","Microfluidics Chip, Droplets, FACS",,,TRUE,scRNA-seq Level 1,,,
Dissociation Method,The tissue dissociation method used for scRNASeq assays,gentleMACS,,,TRUE,scRNA-seq Level 1,,,
Library Layout,Sequencing read type,"Paired End, Single Read",,,TRUE,Sequencing,,,
Paired End,A library layout type,,,,FALSE,Sequencing,,,
Read1,Read 1 content description,"Cell Barcode and UMI, cDNA",,,TRUE,scRNA-seq Level 1,,,
Read2,Read 2 content description,"Cell Barcode and UMI, cDNA",,,TRUE,scRNA-seq Level 1,,,
cDNA,"Complementary DNA. A DNA copy of an mRNA or complex sample of mRNAs, made using reverse transcriptase",,"cDNA Offset, cDNA Length",,FALSE,Sequencing,,,
cDNA Offset,Offset in sequence for cDNA read (in bp): number,,,,TRUE,Sequencing,,,
cDNA Length,Length of cDNA read (in bp): number,,,,TRUE,Sequencing,,,
Cell Barcode and UMI,Cell and transcript identifiers,,"UMI Barcode Offset, UMI Barcode Length, Median UMIs per Cell Number, Cell Barcode Offset, Cell Barcode Length, Valid Barcodes Cell Number",,FALSE,scRNA-seq Level 1,,,
Cell Barcode Offset,Offset in sequence for cell barcode read (in bp): number,,,,TRUE,scRNA-seq Level 1,,,
Cell Barcode Length,Length of cell barcode read (in bp): number,,,,TRUE,scRNA-seq Level 1,,,
Valid Barcodes Cell Number,Number,,,,TRUE,scRNA-seq Level 1,,,
UMI Barcode Offset,"Start position of UMI barcode in the sequence. Values: number, 0 for start of read",,,,TRUE,scRNA-seq Level 1,,https://www.ebi.ac.uk/arrayexpress/help/single-cell_submission_guide.html,
UMI Barcode Length,Length of UMI barcode read (in bp): number,,,,TRUE,scRNA-seq Level 1,,,
Median UMIs per Cell Number,Number,,,,TRUE,scRNA-seq Level 1,,,
Library Construction Method,Process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors [OBI_0000711],"Smart-seq2, Smart-SeqV4, 10xV1, 10xV2, 10xV3,10xV3.1, CEL-seq2, Drop-seq, inDropsV2, inDropsV3, TruDrop",,,TRUE,Sequencing,,http://purl.obolibrary.org/obo/OBI_0000711,
Input Cells and Nuclei,"Number of cells and number of nuclei input; entry format: number, number",,,,TRUE,scRNA-seq Level 1,,,
CEL-seq2,Highly-multiplexed plate-based single-cell RNA-Seq assay,,"Empty Well Barcode, Well Index",,FALSE,scRNA-seq Level 1,,,
Empty Well Barcode,Unique cell barcode assigned to empty cells used as controls in CEL-seq2 assays.,,,,TRUE,scRNA-seq Level 1,,,
Well Index,Indicate if protein expression (EPCAM/CD45) positive/negative data  is available for each cell in CEL-seq2 assays,,,,TRUE,scRNA-seq Level 1,,,
Library Preparation Date,"The date that the libraries were prepared for sequencing (in number of days since sample received in lab). A combination of date and time of day in the form [-]CCYY-MM-DDThh:mm:ss[Z|(+|-)hh:mm] or ""null""",,,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Single Cell Dissociation Date,The date when the sample was dissociated and cells were isolated (date format),,,,TRUE,scRNA-seq Level 1,,,
Sequencing Library Construction Date,Date of sequencing library construction part of library construction (in number of days since sample received in lab),,,,TRUE,Sequencing,,,
Nucleic Acid Capture Date,Date of nucleic acid capture part of library construction (in number of days since sample received in lab),,,,TRUE,Sequencing,,,
Cryopreserved Cells in Sample,Indicate if library preparation was based on revived frozen cells.,"Yes, No",,,TRUE,scRNA-seq Level 1,,,
End Bias,"The end of the cDNA molecule that is preferentially sequenced, e.g. 3/5 prime tag/end or the full length transcript","3 Prime, 5 Prime, Full Length Transcript",,,TRUE,scRNA-seq Level 1,,,
Reverse Transcription Primer,"An oligo to which new deoxyribonucleotides can be added by DNA polymerase [SO_0000112]. The type of primer used for reverse transcription, e.g. oligo-dT or random primer. This allows users to identify content of the cDNA library input e.g. enriched for mRNA","Oligo-dT, Poly-dT, Feature barcoding, Random",,,TRUE,scRNA-seq Level 1,,http://www.sequenceontology.org/so_wiki/index.php/Category:SO:0000112_!_primer,
Feature barcoding,A method for adding extra channels of information to cells by running single-cell gene expression in parallel with other assays [https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/feature-bc],,Feature Reference Id,,FALSE,scRNA-seq Level 1,,https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/feature-bc,
Feature Reference Id,"Unique ID for this feature. Must not contain whitespace, quote or comma characters. Each ID must be unique and must not collide with a gene identifier from the transcriptome [https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/using/feature-bc-analysis#feature-ref]",,,,TRUE,scRNA-seq Level 1,,,
Spike In,A set of known synthetic RNA molecules with known sequence that are added to the cell lysis mix,"ERCC, Other Spike In, No Spike In, PhiX",,,TRUE,scRNA-seq Level 1,,,
ERCC,The External RNA Controls Consortium (ERCC) spike in set is commonly used in single-cell experiments for normalization,"Spike In Mix 1, Spike In Mix 2, Both Spike in Mixes",Spike In Concentration,,FALSE,Spike In,,,
Spike In Concentration,The final concentration or dilution (for commercial sets) of the spike in mix [PMID:21816910],,,,TRUE,ERCC,,https://www.ncbi.nlm.nih.gov/pubmed/21816910,
Sequencing Platform,A platform is an object aggregate that is the set of instruments and software needed to perform a process [OBI_0000050]. Specific model of the sequencing instrument.,"Illumina Next Seq 500, Illumina Next Seq 2500, Illumina NovaSeq 6000, 454 GS FLX Titanium, AB SOLiD 4 AB SOLiD 2, AB SOLiD 3, Complete Genomics, Illumina HiSeq X Ten, Illumina HiSeq X Five, Illumina Genome Analyzer II, Illumina Genome Analyzer IIx, Illumina HiSeq 2000, Illumina HiSeq 2500, Illumina HiSeq 4000, Illumina MiSeq, Illumina NextSeq, Ion Torrent PGM, Ion Torrent Proton, Ion Torrent S5, PacBio RS, Other, Unknown, Not Reported",,,TRUE,Device,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Technical Replicate Group,A common term for all files belonging to the same cell or library. Provide a numbering of each library prep batch (can differ from encapsulation and sequencing batch),,,,FALSE,Sequencing,,,
Total Number of Input Cells,Number of cells loaded/placed on plates,,,,TRUE,Sequencing,,,
Protocols Link,"Protocols.io ID  or DOI link to a free/open protocol resource describing in detail the assay protocol (e.g. surface markers used in Smart-seq, dissociation duration,  lot/batch numbers for key reagents such as primers, sequencing reagent kits, etc.).",,,,TRUE,Assay,,,
Sequencing Batch ID,Links samples to a specific local sequencer run. Can be string or 'null',,,,TRUE,Sequencing,,,
Read Length,"The length of the sequencing reads. Can be integer, null",,,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Library Selection Method,How RNA molecules are isolated.,"Hybrid Selection, PCR, Affinity Enrichment, Poly-T Enrichment, Random, rRNA Depletion, miRNA Size Fractionation, Other",,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Library Preparation Kit Name,Name of Library Preparation Kit. String,,,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Library Preparation Kit Vendor,Vendor of Library Preparation Kit. String,,,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Library Preparation Kit Version,Version of Library Preparation Kit. String,,,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Adapter Name,Name of the sequencing adapter. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Adapter Sequence,Base sequence of the sequencing adapter. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Base Caller Name,Name of the base caller. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Base Caller Version,Version of the base caller. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Flow Cell Barcode,Flow cell barcode. Wrong or missing information may affect analysis results. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Fragment Maximum Length,"Maximum length of the sequenced fragments (e.g., as predicted by Agilent Bioanalyzer). Integer",,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Fragment Mean Length,"Mean length of the sequenced fragments (e.g., as predicted by Agilent Bioanalyzer). Number",,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Fragment Minimum Length,"Minimum length of the sequenced fragments (e.g., as predicted by Agilent Bioanalyzer). Integer",,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Fragment Standard Deviation Length,"Standard deviation of the sequenced fragments length (e.g., as predicted by Agilent Bioanalyzer). Number",,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Lane Number,"The basic machine unit for sequencing. For Illumina machines, this reflects the physical lane number. Wrong or missing information may affect analysis results. Integer",,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Library Strand,Library stranded-ness.,"Unstranded, First Stranded, Second Stranded, Not Applicable",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Multiplex Barcode,The barcode/index sequence used. Wrong or missing information may affect analysis results. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Size Selection Range,Range of size selection. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Target Depth,The targeted read depth prior to sequencing. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
To Trim Adapter Sequence,Does the user suggest adapter trimming?,"Yes, No",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group,
Transcript Integrity Number (TIN),"Used to describe the quality of the starting material, esp. in regards to FFPE samples. Number",,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
RIN,A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample including the presence or absence of degradation products. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
DV200,Represents the percentage of RNA fragments that are >200 nucleotides in size. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Adapter Content,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Basic Statistics,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Encoding,Version of ASCII encoding of quality values found in the file. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Kmer Content,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Overrepresented Sequences,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Per Base N Content,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Per Base Sequence Content,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Per Base Sequence Quality,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Per Sequence GC Content,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Per Sequence Quality Score,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Per Tile Sequence Quality,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Percent GC Content,The overall %GC of all bases in all sequences. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Sequence Duplication Levels,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Sequence Length Distribution,State classification given by FASTQC for the metric. Metric specific details about the states are available on their website.,"FAIL, PASS, WARN, Unknown, Not Reported",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Total Reads,Total number of reads. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
QC Workflow Type,Generic name for the workflow used to analyze a data set. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
QC Workflow Version,Major version for a GDC workflow. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
QC Workflow Link,Link to workflow used. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=read_group_qc,
Alignment Workflow Url,Link to workflow used for read alignment. DockStore.org recommended. String,,,,TRUE,Sequencing,,,
Alignment Workflow Type,Generic name for the workflow used to analyze a data set.,"BWA, BWA with BQSR, BWA-aln, BWA-mem, BWA with Mark Duplicates and BQSR, STAR 2-Pass, STAR 2-Pass Chimeric, STAR 2-Pass Genome, STAR 2-Pass Transcriptome",,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=alignment_workflow,
Genomic Reference,The human genome reference used in the alignment of reads. String,,,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=alignment_workflow,
Genomic Reference URL,URL refering to specific reference used. String,,,,TRUE,Sequencing,,,
Index File Name,The name (or part of a name) of a file (of any type). String,,,,TRUE,Sequencing,,,
Average Base Quality,Average base quality collected from samtools. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads_index,
Average Insert Size,Average insert size collected from samtools. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Average Read Length,Average read length collected from samtools. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Contamination,Fraction of reads coming from cross-sample contamination collected from GATK4. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Contamination Error,Estimation error of cross-sample contamination collected from GATK4. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Mean Coverage,"Mean coverage for whole genome sequencing, or mean target coverage for whole exome and targeted sequencing, collected from Picard Tools. Number",,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
MSI Workflow Name/URL,Method used in estimating the MSI. String,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
MSI Score,Numeric score denoting the aligned reads file's MSI score from MSIsensor. Number,,,,FALSE,Sequencing,,,
MSI Status,MSIsensor determination of either microsatellite stability or instability.,"MSI, MSI-low, MSI-high, MSS",,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Pairs On Diff CHR,Pairs on different chromosomes collected from samtools. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Total Reads,Total number of reads collected from samtools. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Total Uniquely Mapped,Number of reads that map to genome. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Total Unmapped reads,Number of reads that did not map to genome. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Proportion Reads Duplicated,Proportion of duplicated reads collected from samtools. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Proportion Reads Mapped,Proportion of mapped reads collected from samtools. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Proportion Targets No Coverage,Proportion of targets that did not reach 1X coverage over any base from Picard Tools. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Proportion Base Mismatch,Proportion of mismatched bases collected from samtools. Number,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Short Reads,Number of reads that were too short. Integer,,,,FALSE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=aligned_reads,
Psuedo Alignment Used,Psuedo aligners such as Kallisto or Salmon do not produce aligned reads BAM files. True indicates pseudoalignment was used.,"Yes, No",,,TRUE,Sequencing,,,
Workflow URL or command,Link to workflow document. DockStore.org recommended. String,,Psuedo Alignment Used,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=rna_expression_workflow,
Software and version,Name of software used to generate expression values. String,,Psuedo Alignment Used,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=rna_expression_workflow,
Genomic Reference,The human genome reference used in the alignment of reads.,GRCh38,Psuedo Alignment Used,,TRUE,Sequencing,,,
Genomic Reference URL,URL refering to exact reference used. String,,Psuedo Alignment Used,,TRUE,Sequencing,,,
Data Format,Format of the data files.,"CSV, HDF5, TSV, TXT",,,TRUE,File,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=gene_expression,
Data Category,Specific content type of the data file.,"Exon Expression Quantification, Gene Expression Quantification, Isoform Expression Quantification, Splice Junction Quantification",,,TRUE,Sequencing,,https://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=gene_expression,
Expression Units,How quantities are corrected for gene length,"TPM, RPKM, FPKM, Counts, Other, NA",,,TRUE,Sequencing,,,
Matrix Type,Type of data stored in matrix.,"Raw Counts, Normalized Counts, Scaled Counts, Batch Corrected Counts",,,TRUE,Sequencing,,,
Ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.","hispanic or latino, not hispanic or latino, Unknown, not reported, not allowed to collect",,,TRUE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2192217&version=2.0,
Gender,"Text designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]","female, male, unknown, unspecified, not reported",,,TRUE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2200604&version=3.0,
Race,"An arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation withina a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution.","white, american indian or alaska native, black or african american, asian, native hawaiian or other pacific islander, other, Unknown, not reported, not allowed to collect",,,TRUE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2192199&version=1.0,
Vital Status,The survival state of the person registered on the protocol.,"Alive, Dead, Unknown, Not Reported",,,TRUE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5&version=5.0,
Dead,This indicates the participant is dead and defines further required metadata,,"Year of Death, Cause of Death, Cause of Death Source, Days to Death",,FALSE,Demographics,,,
Days to Birth,Number of days between the date used for index and the date from a person's date of birth represented as a calculated negative number of days.,,,,TRUE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154723&version=1.0,
Year of Death,Numeric value to represent the year of the death of an individual.,Not Applicable,,,TRUE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2897030&version=1.0,
Age at Index,For GDC submission only - this is going to be always 0 since HTAN's index is the date of birth,null,,,FALSE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6028530&version=1.0,
Age Is Obfuscated,The age of the patient has been modified for compliance reasons. The actual age differs from what is reported. Other date intervals for this patient may also be modified.,"true, false",,,FALSE,Demographics,,,
Year Of Birth,Numeric value to represent the calendar year in which an individual was born.,null,,,FALSE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2896954&version=1.0,
Cause of Death,The cause of death,"Cancer Related, Cardiovascular Disorder NOS, End-stage Renal Disease, Infection, Not Cancer Related, Renal Disorder NOS, Spinal Muscular Atrophy, Surgical Complications, Toxicity, Not Reported, Unknown, Not Applicable",,,TRUE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2554674&version=3.0,
Cause of Death Source,The text term used to describe the source used to determine the patient's cause of death.,"Autopsy, Death Certificate, Medical Record, Social Security Death Index, Unknown, Not Reported",,,FALSE,Demographics,,,
Days to Death,Number of days between the date used for index and the date from a person's date of death represented as a calculated number of days.,,,,FALSE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154724&version=1.0,
Occupation Duration Years,The number of years a patient worked in a specific occupation.,,,,FALSE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2435424&version=1.0,
Premature At Birth,The yes/no/unknown indicator used to describe whether the patient was premature (less than 37 weeks gestation) at birth.,"Yes, No, Unknown, Not Reported",,,FALSE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6010765&version=1.0,
Weeks Gestation at Birth,Numeric value used to describe the number of weeks starting from the approximate date of the biological mother's last menstrual period and ending with the birth of the patient.,,,,FALSE,Demographics,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2737369&version=1.0,
Relationship Gender,The text term used to describe the gender of the patient's relative with a history of cancer.,"Female, Male, unknown, unspecified, Not Reported",,,FALSE,Family History,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161021&version=1.0,
Relationship Age at Diagnosis,The age (in years) when the patient's relative was first diagnosed.,,,,FALSE,Family History,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5300571&version=1.0,
Relationship Primary Diagnosis,The text term used to describe the malignant diagnosis of the patient's relative with a history of cancer.,"Adrenal Gland Cancer, Basal Cell Cancer, Bile Duct Cancer, Bladder Cancer, Blood Cancer, Bone Cancer, Brain Cancer, Breast Cancer, Cancer, Cervical Cancer, Chondrosarcoma, CNS Cancer, Colorectal Cancer, Esophageal Cancer, Ewing Sarcoma, Gallbladder Cancer, Gastric Cancer, Glioblastoma, Gynecologic Cancer, Head and Neck Cancer, Hematologic Cancer, Kaposi Sarcoma, Kidney Cancer, Laryngeal Cancer, Leukemia, Liver Cancer, Lung Cancer, Lymph Node Cancer, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Neuroblastoma, Osteosarcoma, Ovarian Cancer, Pancreas Cancer, Prostate Cancer, Rectal Cancer, Rhabdomyosarcoma, Sarcoma, Skin Cancer, Spleen Cancer, Testicular Cancer, Throat Cancer, Thyroid Cancer, Tongue Cancer, Tonsillar Cancer, Uterine Cancer, Wilms Tumor, Unknown, Not Reported",,,FALSE,Family History,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161022&version=1.0,
Relationship Type,The subgroup that describes the state of connectedness between members of the unit of society organized around kinship ties.,"Adopted Daughter, Adopted Son, Adoptive Brother, Adoptive Father, Adoptive Mother, Adoptive Sister, Aunt, Brother, Brother-in-law, Child, Cousin, Daughter, Daughter-in-law, Domestic Partner, Father, Father-in-law, Female Cousin, First Cousin, First Cousin Once Removed, Foster Brother, Foster Daughter, Foster Father, Foster Mother, Foster Sister, Foster Son,  Fraternal Twin Brother, Fraternal Twin Sibling, Fraternal Twin Sister,      Full Brother, Full Sister, Grand Nephew, Grand Niece, Grandchild, Granddaughter, Grandfather, Grandmother, Grandparent, Grandson, Great Grandchild, Half Brother, Half Sibling, Half Sister, Husband, Identical Twin Brother, Identical Twin Sibling, Identical Twin Sister, Legal Guardian, Male Cousin, Maternal Aunt, Maternal First Cousin, Maternal First Cousin Once Removed, Maternal Grandfather, Maternal Grandmother, Maternal Grandparent, Maternal Great Aunt, Maternal Great Grandparent, Maternal Great Uncle, Maternal Half Brother, Maternal Half Sibling, Maternal Half Sister, Maternal Uncle, Mother, Mother-in-law, Natural Brother, Natural Child, Natural Daughter, Natural Father, Natural Grandchild, Natural Grandfather, Natural Grandmother, Natural Grandparent, Natural Mother, Natural Parent, Natural Sibling, Natural Sister, Natural Son, Nephew, Niece, Niece Second Degree Relative, Other, Parent, Paternal Aunt, Paternal First Cousin, Paternal First Cousin Once Removed, Paternal Grandfather, Paternal Grandmother, Paternal Grandparent, Paternal Great Aunt, Paternal Great Grandparent, Paternal Great Uncle, Paternal Half Brother, Paternal Half Sibling, Paternal Half Sister, Paternal Uncle, Refused, Sibling, Sister, Sister-in-law, Son, Son-in-law, Spouse, Step Child, Step Sibling, Stepbrother, Stepdaughter, Stepfather, Stepmother, Stepsister, Stepson, Twin Sibling, Uncle, Unrelated, Ward, Wife, Unknown, Not Reported",,,FALSE,Family History,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2690165&version=2.0,
Relative with Cancer History,The yes/no/unknown indicator used to describe whether any of the patient's relatives have a history of cancer.,"Yes - Cancer History Relative, None, Unknown, Not reported",,,FALSE,Family History,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161023&version=1.0,
Relatives with Cancer History Count,The number of relatives the patient has with a known history of cancer.,,,,FALSE,Family History,,,
Yes - Cancer History Relative,Individual has a relative with cancer history,,"Relatives with Cancer History Count, Relationship Type, Relationship Primary Diagnosis, Relationship Gender,Relationship Age at Diagnosis",,FALSE,Family History,,,
Smoking Exposure,Indicate if individual has smoking exposure,"Yes - Smoking Exposure, No - Smoking Exposure, Not Reported",,,TRUE,Exposure,,,
Yes - Smoking Exposure,Individual has been exposed to smoke; requires additional metadata,,"Years Smoked, Pack Years Smoked, Cigarettes per Day, Smoking Frequency, Time between Waking and First Smoke, Tobacco Smoking Onset Year, Tobacco Smoking Quit Year, Tobacco Smoking Status, Type of Tobacco Used",,FALSE,Exposure,,,
Pack Years Smoked,Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.,,,,TRUE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2955385&version=1.0,
Years Smoked,Numeric value (or unknown) to represent the number of years a person has been smoking.,,,,TRUE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3137957&version=1.0,
Alcohol Exposure,Indicate if individual has alcohol exposure,"Yes - Alcohol Exposure, No - Alcohol Exposure, Not Reported",,,TRUE,Exposure,,,
Yes - Alcohol Exposure,,,"Alcohol Days Per Week, Alcohol Drinks Per Day, Alcohol History, Alcohol Intensity",,FALSE,Exposure,,,
Alcohol Days Per Week,Numeric value used to describe the average number of days each week that a person consumes an alcoholic beverage.,,,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3114013&version=1.0,
Alcohol Drinks Per Day,Numeric value used to describe the average number of alcoholic beverages a person consumes per day.,,,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3124961&version=1.0,
Alcohol History,A response to a question that asks whether the participant has consumed at least 12 drinks of any kind of alcoholic beverage in their lifetime.,"Yes, No, Unknown, Not Reported",,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2201918&version=1.0,
Alcohol Intensity,Category to describe the patient's current level of alcohol use as self-reported by the patient.,"Drinker, Heavy Drinker, Lifelong Non-Drinker, Non-Drinker, Occasional Drinker, Unknown, Not Reported",,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3457767&version=1.0,
Asbestos Exposure,The yes/no/unknown indicator used to describe whether the patient was exposed to asbestos.,"Yes, No, Unknown, Not Reported",,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=1253&version=3.0,
Cigarettes per Day,The average number of cigarettes smoked per day.,,,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2001716&version=4.0,
Coal Dust Exposure,The yes/no/unknown indicator used to describe whether a patient was exposed to fine powder derived by the crushing of coal.,"Yes, No, Unknown",,,FALSE,Exposure,,,
Environmental Tobacco Smoke Exposure,"The yes/no/unknown indicator used to describe whether a patient was exposed to smoke that is emitted from burning tobacco, including cigarettes, pipes, and cigars. This includes tobacco smoke exhaled by smokers.","Yes, No, Unknown",,,FALSE,Exposure,,,
Radon Exposure,The yes/no/unknown indicator used to describe whether the patient was exposed to radon.,"Yes, No, Unknown, Not Reported",,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2816352&version=1.0,
Respirable Crystalline Silica Exposure,"The yes/no/unknown indicator used to describe whether a patient was exposured to respirable crystalline silica, a widespread, naturally occurring, crystalline metal oxide that consists of different forms including quartz, cristobalite, tridymite, tripoli, ganister, chert and novaculite.","Yes, No, Unknown",,,FALSE,Exposure,,,
Smoking Frequency,The text term used to generally decribe how often the patient smokes.,"Every day, Some days, Unknown",,,FALSE,Exposure,,,
Time Between Waking and First Smoke,The text term used to describe the approximate amount of time elapsed between the time the patient wakes up in the morning to the time they smoke their first cigarette.,"Within 5 Minutes, 6-30 Minutes, 31-60 Minutes, After 60 Minutes, Unknown",,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3279220&version=1.0,
Tobacco Smoking Onset Year,The year in which the participant began smoking.,,,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2228604&version=1.0,
Tobacco Smoking Quit Year,The year in which the participant quit smoking.,,,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2228610&version=1.0,
Tobacco Smoking Status,Category describing current smoking status and smoking history as self-reported by a patient,"Lifelong Non-Smoker, Current Smoker, Current Reformed Smoker for > 15 yrs, Current Reformed Smoker for < or = 15 yrs, Current Reformed Smoker, Duration Not Specified, Smoking history not documented, Unknown, Not Reported",,,FALSE,Exposure,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2181650&version=1.0,
Type of Smoke Exposure,The text term used to describe the patient's specific type of smoke exposure.,"Accidental building fire smoke,Accidental grass fire smoke, Accidental fire smoke NOS,Accidental forest fire smoke,Accidental vehicle fire smoke,Aircraft smoke,Burning tree smoke,Coal smoke NOS, Cooking related smoke NOS,Electronic cigarette smoke NOS,Electrical fire smoke,Environmental tobacco smoke,Factory smokestack smoke,Field burning smoke,Fire smoke NOS,Furnace or boiler smoke,Gas burning smoke propane,Grease fire smoke,Grilling smoke,Hashish smoke,Indoor coal burning stove or fireplace smoke,Indoor stove or fireplace smoke NOS,Indoor wood burning stove or fireplace smoke,Machine smoke,Marijuana smoke,No Smoke Exposure,Oil burning smoke Kerosene,Oil burning smoke NOS,Recreational fire smoke,Smoke exposure NOS,Smokehouse smoke,Tobacco smoke cigar,Tobacco smoke cigarettes,Tobacco smoke pipe,Unknown,Volcanic smoke,Waste burning smoke,Wood burning smoke factory,Wood burning smoke NOS, Workrelated smoke artificial smoke machines, Workrelated smoke fire fighting,Workrelated smoke foundry,Workrelated smoke generators,Workrelated smoke military,Workrelated smoke NOS,Workrelated smoke paint baking,Workrelated smoke plastics factory,Workrelated smoke plumbing,Workrelated smoke soldering/welding",,,FALSE,Exposure,,,
Type of Tobacco Used,The text term used to describe the specific type of tobacco used by the patient.,"Cigarettes, Cigar, Electronic Cigarette, Other, Pipe, Smokeless Tobacco",,,FALSE,Exposure,,,
Days to Follow Up,Number of days between the date used for index and the date of the patient's last follow-up appointment or contact.,,,,TRUE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154727&version=1.0,
Adverse Event,Text that represents the Common Terminology Criteria for Adverse Events low level term name for an adverse event.,"Abdominal Distension, Abdominal Infection,Abdominal Pain,Abdominal Soft Tissue Necrosis,Abducens Nerve Disorder,Accessory Nerve Disorder,Acidosis,Acoustic Nerve Disorder NOS,Activated Partial Thromboplastin Time Prolonged,Acute Coronary Syndrome,Acute Kidney Injury,Adrenal Insufficiency,Adult Respiratory Distress Syndrome, Agitation, Akathisia, Alanine Aminotransferase Increased,Alcohol Intolerance,Alkaline Phosphatase Increased,Alkalosis,Allergic Reaction,Allergic Rhinitis, Alopecia, Amnesia,Anal Fistula,Anal Hemorrhage,Anal Mucositis, Anal Necrosis,Anal Pain,Anal Stenosis,Anal Ulcer,Anaphylaxis,Anemia,Ankle Fracture,Anorectal Infection,Anorexia,Anorgasmia,Anxiety,Aortic Injury,Aortic Valve Disease,Aphonia,Apnea,Appendicitis,Appendicitis Perforated,Arachnoiditis,Arterial Injury,Arteritis Infective,Arthralgia,Arthritis,Ascites,Aspartate Aminotransferase Increased,Aspiration,Asystole,Ataxia,Atelectasis,Atrial Fibrillation,Atrial Flutter,Atrioventricular Block Complete,Atrioventricular Block First Degree,Autoimmune Disorder,Avascular Necrosis,Azoospermia,Back Pain,Bile Duct Stenosis,Biliary Anastomotic Leak,Biliary Fistula,Biliary Tract Infection,Bladder Anastomotic Leak,Bladder Infection,Bladder Perforation,Bladder Spasm,Bloating,Blood and Lymphatic System Disorders Other,Blood Antidiuretic Hormone Abnormal,Blood Bilirubin Increased,Blood Corticotrophin Decreased,Blood Gonadotrophin Abnormal,Blood Prolactin Abnormal,Blurred Vision,Body Odor,Bone Infection,Bone Marrow Hypocellular,Bone Pain,Brachial Plexopathy,Breast Atrophy,Breast Infection,Breast Pain,Bronchial Fistula,Bronchial Infection,Bronchial Obstruction,Bronchial Stricture,Bronchopleural Fistula,Bronchopulmonary Hemorrhage,Bronchospasm,Bruising,Bullous Dermatitis,Burn,Buttock Pain,Capillary Leak Syndrome,Carbon Monoxide Diffusing Capacity Decreased,Cardiac Arrest,Cardiac Disorders Other,Cardiac Troponin I Increased,Cardiac Troponin T Increased,Cataract,Catheter Related Infection,CD4 Lymphocytes Decreased,Cecal Hemorrhage,Cecal Infection,Central Nervous System Necrosis,Cerebrospinal Fluid Leakage,Cervicitis Infection,Cheilitis,Chest Pain Cardiac,Chest Wall Pain,Chills,Cholecystitis,Cholesterol High,Chronic Kidney Disease,Chylothorax,Cognitive Disturbance,Colitis,Colonic Fistula,Colonic Hemorrhage,Colonic Obstruction,Colonic Perforation,Colonic Stenosis,Colonic Ulcer,Concentration Impairment,Conduction Disorder,Confusion,Congenital, Familial and Genetic Disorders Other,Conjunctivitis,Conjunctivitis Infective,Constipation,Constrictive Pericarditis,Corneal Infection,Corneal Ulcer,Cough,CPK Increased,Cranial Nerve Infection,Creatinine Increased,Cushingoid,Cystitis Noninfective,Cytokine Release Syndrome,Death Neonatal,Death NOS,Dehydration,Delayed Orgasm,Delayed Puberty,Delirium,Delusions,Dental Caries,Depressed Level of Consciousness,Depression,Dermatitis Radiation,Device Related Infection,Diarrhea,Disseminated Intravascular Coagulation,Dizziness,Dry Eye,Dry Mouth,Dry Skin,Duodenal Fistula,Duodenal Hemorrhage,Duodenal Infection,Duodenal Obstruction,Duodenal Perforation,Duodenal Stenosis,Duodenal Ulcer,Dysarthria,Dysesthesia,Dysgeusia,Dysmenorrhea,Dyspareunia,Dyspepsia,Dysphagia,Dysphasia,Dyspnea,Ear and Labyrinth Disorders Other,Ear Pain,Edema Cerebral,Edema Face,Edema Limbs,Edema Trunk,Ejaculation Disorder,Ejection Fraction Decreased,Electrocardiogram QT Corrected Interval Prolonged,Encephalitis Infection,Encephalomyelitis Infection,Encephalopathy,Endocarditis Infective,Endocrine Disorders Other,Endophthalmitis,Enterocolitis,Enterocolitis Infectious,Enterovesical Fistula,Epistaxis,Erectile Dysfunction,Erythema Multiforme,Erythroderma,Esophageal Anastomotic Leak,Esophageal Fistula,Esophageal Hemorrhage,Esophageal Infection,Esophageal Necrosis,Esophageal Obstruction,Esophageal Pain,Esophageal Perforation,Esophageal Stenosis,Esophageal Ulcer,Esophageal Varices Hemorrhage,Esophagitis,Euphoria,Exostosis,External Ear Inflammation,External Ear Pain,Extraocular Muscle Paresis,Extrapyramidal Disorder,Eye Disorders Other,Eye Infection,Eye Pain,Eyelid Function Disorder,Facial Muscle Weakness,Facial Nerve Disorder,Facial Pain,Fall,Fallopian Tube Anastomotic Leak,Fallopian Tube Obstruction,Fallopian Tube Perforation,Fallopian Tube Stenosis,Fat Atrophy,Fatigue,Febrile Neutropenia,Fecal Incontinence,Female Genital Tract Fistula,Feminization Acquired,Fetal Death,Fetal Growth Retardation,Fever,Fibrinogen Decreased,Fibrosis Deep Connective Tissue,Flank Pain,Flashing Lights,Flatulence,Floaters,Flu Like Symptoms,Flushing,Forced Expiratory Volume Decreased,Fracture,Gait Disturbance,Gallbladder Fistula,Gallbladder Infection,Gallbladder Necrosis,Gallbladder Obstruction,Gallbladder Pain,Gallbladder Perforation,Gastric Anastomotic Leak,Gastric Fistula,Gastric Hemorrhage,Gastric Necrosis,Gastric Perforation,Gastric Stenosis,Gastric Ulcer,Gastritis,Gastroesophageal Reflux Disease,Gastrointestinal Anastomotic Leak,Gastrointestinal Disorders Other,Gastrointestinal Fistula,Gastrointestinal Pain,Gastrointestinal Stoma Necrosis,Gastroparesis,General Disorders and Administration Site Conditions Other,Generalized Muscle Weakness,Genital Edema,GGT Increased,Gingival Pain,Glaucoma,Glossopharyngeal Nerve Disorder,Glucose Intolerance,Growth Accelerated,Growth Hormone Abnormal,Growth Suppression,Gum Infection,Gynecomastia,Hallucinations,Haptoglobin Decreased,Head Soft Tissue Necrosis,Headache,Hearing Impaired,Heart Failure,Hematoma,Hematosalpinx,Hematuria,Hemoglobin Increased,Hemoglobinuria,Hemolysis,Hemolytic Uremic Syndrome,Hemorrhoidal Hemorrhage,Hemorrhoids,Hepatic Failure,Hepatic Hemorrhage,Hepatic Infection,Hepatic Necrosis,Hepatic Pain,Hepatitis Viral,Hepatobiliary Disorders Other,Hiccups,Hip Fracture,Hirsutism,Hoarseness,Hot Flashes,Hydrocephalus,Hypercalcemia,Hyperglycemia,Hyperhidrosis,Hyperkalemia,Hypermagnesemia,Hypernatremia,Hyperparathyroidism,Hypersomnia,Hypertension,Hyperthyroidism,Hypertrichosis,Hypertriglyceridemia,Hyperuricemia,Hypoalbuminemia,Hypocalcemia,Hypoglossal Nerve Disorder,Hypoglycemia,Hypohidrosis,Hypokalemia,Hypomagnesemia,Hyponatremia,Hypoparathyroidism,Hypophosphatemia,Hypotension,Hypothermia,Hypothyroidism,Hypoxia,Ileal Fistula,Ileal Hemorrhage,Ileal Obstruction,Ileal Perforation,Ileal Stenosis,Ileal Ulcer,Ileus,Immune System Disorders Other,Infections and Infestations Other,Infective Myositis,Infusion Related Reaction,Infusion Site Extravasation,Injection Site Reaction,Injury to Carotid Artery,Injury to Inferior Vena Cava,Injury to Jugular Vein,Injury to Superior Vena Cava,Injury, Poisoning and Procedural Complications Other,INR Increased,Insomnia,Intestinal Stoma Leak,Intestinal Stoma Obstruction,Intestinal Stoma Site Bleeding,Intra-Abdominal Hemorrhage,Intracranial Hemorrhage,Intraoperative Arterial Injury,Intraoperative Breast Injury,Intraoperative Cardiac Injury,Intraoperative Ear Injury,Intraoperative Endocrine Injury,Intraoperative Gastrointestinal Injury,Intraoperative Head and Neck Injury,Intraoperative Hemorrhage,Intraoperative Hepatobiliary Injury,Intraoperative Musculoskeletal Injury,Intraoperative Neurological Injury,Intraoperative Ocular Injury,Intraoperative Renal Injury,Intraoperative Reproductive Tract Injury,Intraoperative Respiratory Injury,Intraoperative Skin Injury,Intraoperative Splenic Injury,Intraoperative Urinary Injury,Intraoperative Venous Injury,Investigations Other,Iron Overload,Irregular Menstruation,Irritability,Ischemia Cerebrovascular,IVth Nerve Disorder,Jejunal Fistula,Jejunal Hemorrhage,Jejunal Obstruction,Jejunal Perforation,Jejunal Stenosis,Jejunal Ulcer,Joint Effusion,Joint Infection,Joint Range of Motion Decreased,Joint Range of Motion Decreased Cervical Spine,Joint Range of Motion Decreased Lumbar Spine,Keratitis,Kidney Anastomotic Leak,Kidney Infection,Kyphosis,Lactation Disorder,Large Intestinal Anastomotic Leak,Laryngeal Edema,Laryngeal Fistula,Laryngeal Hemorrhage,Laryngeal Inflammation,Laryngeal Mucositis,Laryngeal Obstruction,Laryngeal Stenosis,Laryngitis,Laryngopharyngeal Dysesthesia,Laryngospasm,Left Ventricular Systolic Dysfunction,Lethargy,Leukemia Secondary to Oncology Chemotherapy,Leukocytosis,Leukoencephalopathy,Libido Decreased,Libido Increased,Lip Infection,Lip Pain,Lipase Increased,Lipohypertrophy,Localized Edema,Lordosis,Lower Gastrointestinal Hemorrhage,Lung Infection,Lymph Gland Infection,Lymph Leakage,Lymph Node Pain,Lymphedema,Lymphocele,Lymphocyte Count Decreased,Lymphocyte Count Increased,Malabsorption,Malaise,Mania,Mediastinal Hemorrhage,Mediastinal Infection,Memory Impairment,Meningismus,Meningitis,Menopause,Menorrhagia,Metabolism and Nutrition Disorders Other,Middle Ear Inflammation,Mitral Valve Disease,Mobitz (Type) II Atrioventricular Block,Mobitz Type I,Movements Involuntary,Mucosal Infection,Mucositis Oral,Multi-Organ Failure,Muscle Weakness Left-Sided,Muscle Weakness Lower Limb,Muscle Weakness Right-Sided,Muscle Weakness Trunk,Muscle Weakness Upper Limb,Musculoskeletal and Connective Tissue Disorders Other,Musculoskeletal Deformity,Myalgia,Myelitis,Myelodysplastic Syndrome,Myocardial Infarction,Myocarditis,Myositis,Nail Discoloration,Nail Infection,Nail Loss,Nail Ridging,Nasal Congestion,Nausea,Neck Edema,Neck Pain,Neck Soft Tissue Necrosis,Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) Other,Nervous System Disorders Other,Neuralgia,Neutrophil Count Decreased,Night Blindness,Nipple Deformity,Non-Cardiac Chest Pain,Nystagmus,Obesity,Obstruction Gastric,Oculomotor Nerve Disorder,Olfactory Nerve Disorder,Oligospermia,Optic Nerve Disorder,Oral Cavity Fistula,Oral Dysesthesia,Oral Hemorrhage,Oral Pain,Osteonecrosis of Jaw,Osteoporosis,Otitis Externa,Otitis Media,Ovarian Hemorrhage,Ovarian Infection,Ovarian Rupture,Ovulation Pain,Pain,Pain in Extremity,Pain of Skin,Palmar-Plantar Erythrodysesthesia Syndrome,Palpitations,Pancreas Infection,Pancreatic Anastomotic Leak,Pancreatic Duct Stenosis,Pancreatic Enzymes Decreased,Pancreatic Fistula,Pancreatic Hemorrhage,Pancreatic Necrosis,Pancreatitis,Papilledema,Papulopustular Rash,Paresthesia,Paronychia,Paroxysmal Atrial Tachycardia,Pelvic Floor Muscle Weakness,Pelvic Infection,Pelvic Pain,Pelvic Soft Tissue Necrosis,Penile Infection,Penile Pain,Perforation Bile Duct,Pericardial Effusion,Pericardial Tamponade,Pericarditis,Perineal Pain,Periodontal Disease,Periorbital Edema,Periorbital Infection,Peripheral Ischemia,Peripheral Motor Neuropathy,Peripheral Nerve Infection,Peripheral Sensory Neuropathy,Peritoneal Infection,Peritoneal Necrosis,Personality Change,Phantom Pain,Pharyngeal Anastomotic Leak,Pharyngeal Fistula,Pharyngeal Hemorrhage,Pharyngeal Mucositis,Pharyngeal Necrosis,Pharyngeal Stenosis,Pharyngitis,Pharyngolaryngeal Pain,Phlebitis,Phlebitis Infective,Photophobia,Photosensitivity,Platelet Count Decreased,Pleural Effusion,Pleural Hemorrhage,Pleural Infection,Pleuritic Pain,Pneumonitis,Pneumothorax,Portal Hypertension,Portal Vein Thrombosis,Postnasal Drip,Postoperative Hemorrhage,Postoperative Thoracic Procedure Complication,Precocious Puberty,Pregnancy, Puerperium and Perinatal Conditions Other,Premature Delivery,Premature Menopause,Presyncope,Proctitis,Productive Cough,Prolapse of Intestinal Stoma,Prolapse of Urostomy,Prostate Infection,Prostatic Hemorrhage,Prostatic Obstruction,Prostatic Pain,Proteinuria,Pruritus,Psychiatric Disorders Other,Psychosis,Pulmonary Edema,Pulmonary Fibrosis,Pulmonary Fistula,Pulmonary Hypertension,Pulmonary Valve Disease,Purpura,Pyramidal Tract Syndrome,Radiation Recall Reaction (Dermatologic),Radiculitis,Rash Acneiform,Rash Maculo-Papular,Rash Pustular,Rectal Anastomotic Leak,Rectal Fistula,Rectal Hemorrhage,Rectal Mucositis,Rectal Necrosis,Rectal Obstruction,Rectal Pain,Rectal Perforation,Rectal Stenosis,Rectal Ulcer,Recurrent Laryngeal Nerve Palsy,Renal and Urinary Disorders Other,Renal Calculi,Renal Colic,Renal Hemorrhage,Reproductive System and Breast Disorders Other,Respiratory Failure,Respiratory, Thoracic and Mediastinal Disorders Other,Restlessness,Restrictive Cardiomyopathy,Retinal Detachment,Retinal Tear,Retinal Vascular Disorder,Retinoic Acid Syndrome,Retinopathy,Retroperitoneal Hemorrhage,Reversible Posterior Leukoencephalopathy Syndrome,Rhinitis Infective,Right Ventricular Dysfunction,Salivary Duct Inflammation,Salivary Gland Fistula,Salivary Gland Infection,Scalp Pain,Scleral Disorder,Scoliosis,Scrotal Infection,Scrotal Pain,Seizure,Sepsis,Seroma,Serum Amylase Increased,Serum Sickness,Sick Sinus Syndrome,Sinus Bradycardia,Sinus Disorder,Sinus Pain,Sinus Tachycardia,Sinusitis,Skin and Subcutaneous Tissue Disorders Other,Skin Atrophy,Skin Hyperpigmentation,Skin Hypopigmentation,Skin Induration,Skin Infection,Skin Ulceration,Sleep Apnea,Small Intestinal Anastomotic Leak,Small Intestinal Mucositis,Small Intestinal Obstruction,Small Intestinal Perforation,Small Intestinal Stenosis,Small Intestine Infection,Small Intestine Ulcer,Sneezing,Social Circumstances Other,Soft Tissue Infection,Soft Tissue Necrosis Lower Limb,Soft Tissue Necrosis Upper Limb,Somnolence,Sore Throat,Spasticity,Spermatic Cord Anastomotic Leak,Spermatic Cord Hemorrhage,Spermatic Cord Obstruction,Spinal Fracture,Spleen Disorder,Splenic Infection,Stenosis of Gastrointestinal Stoma,Stevens-Johnson Syndrome,Stoma Site Infection,Stomach Pain,Stomal Ulcer,Stridor,Stroke,Sudden Death NOS,Suicidal Ideation,Suicide Attempt,Superficial Soft Tissue Fibrosis,Superficial Thrombophlebitis,Superior Vena Cava Syndrome,Supraventricular Tachycardia,Surgical and Medical Procedures Other,Syncope,Telangiectasia,Testicular Disorder,Testicular Hemorrhage,Testicular Pain,Thromboembolic Event,Thrombotic Thrombocytopenic Purpura,Tinnitus,Tooth Development Disorder,Tooth Discoloration,Tooth Infection,Toothache,Toxic Epidermal Necrolysis,Tracheal Fistula,Tracheal Hemorrhage,Tracheal Mucositis,Tracheal Obstruction,Tracheal Stenosis,Tracheitis,Tracheostomy Site Bleeding,Transient Ischemic Attacks,Treatment Related Secondary Malignancy,Tremor,Tricuspid Valve Disease,Trigeminal Nerve Disorder,Trismus,Tumor Lysis Syndrome,Tumor Pain,Typhlitis,Unequal Limb Length,Unintended Pregnancy,Upper Gastrointestinal Hemorrhage,Upper Respiratory Infection,Ureteric Anastomotic Leak,Urethral Anastomotic Leak,Urethral Infection,Urinary Fistula,Urinary Frequency,Urinary Incontinence,Urinary Retention,Urinary Tract Infection,Urinary Tract Obstruction,Urinary Tract Pain,Urinary Urgency,Urine Discoloration,Urine Output Decreased,Urostomy Leak,Urostomy Obstruction,Urostomy Site Bleeding,Urostomy Stenosis,Urticaria,Uterine Anastomotic Leak,Uterine Fistula,Uterine Hemorrhage,Uterine Infection,Uterine Obstruction,Uterine Pain,Uterine Perforation,Uveitis,Vaginal Anastomotic Leak,Vaginal Discharge,Vaginal Dryness,Vaginal Fistula,Vaginal Hemorrhage,Vaginal Infection,Vaginal Inflammation,Vaginal Obstruction,Vaginal Pain,Vaginal Perforation,Vaginal Stricture,Vaginismus,Vagus Nerve Disorder,Vas Deferens Anastomotic Leak,Vascular Access Complication,Vascular Disorders Other,Vasculitis,Vasovagal Reaction,Venous Injury,Ventricular Arrhythmia,Ventricular Fibrillation,Ventricular Tachycardia,Vertigo,Vestibular Disorder,Virilization,Visceral Arterial Ischemia,Vital Capacity Abnormal,Vitreous Hemorrhage,Voice Alteration,Vomiting,Vulval Infection,Watering Eyes,Weight Gain,Weight Loss,Wheezing,White Blood Cell Decreased,Wolff-Parkinson-White Syndrome,Wound Complication,Wound Dehiscence,Wound Infection,Wrist Fracture",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3125302&version=1.1,
BMI,A calculated numerical quantity that represents an individual's weight to height ratio.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2006410&version=3.0,
Cause of Response,The text term used to describe the suspected cause or reason for the patient disease response.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161025&version=1.0,
Comorbidity,"The text term used to describe a comorbidity disease, which coexists with the patient's malignant disease.","Acute Renal Failure, Adenocarcinoma, Adrenocortical Insufficiency, Adenomatous Polyposis Coli, Allergies, Alpha-1 Antitrypsin, Anemia, Anxiety, Arrhythmia, Arthritis, Asthma, Atrial Fibrillation, Avascular Necrosis, Barrett's Esophagus,Basal Cell Carcinoma, Beckwith-Wiedemann, Behcet's Disease, Biliary Disorder, Blood Clots, Bone Fracture(s), Bronchitis, Calcium Channel Blockers, Cancer, Cataracts, Celiac Disease, Cirrhosis, Unknown Etiology, Cerebrovascular Disease, Cholelithiasis, Chronic Renal Failure, Colon Polyps, Common Variable Immunodeficiency, Congestive Heart Failure (CHF), Connective Tissue Disorder, COPD, Coronary Artery Disease, Crohn's Disease, Cryptogenic Organizing Pneumonia, Deep Vein Thrombosis / Thromboembolism, Denys-Drash Syndrome, Depression, Diabetes, Diabetes, Type II, Diabetic Neuropathy, Diet Controlled Diabetes, Diverticulitis,DVT/PE, Dyslipidemia, Epilepsy, Eczema, Epstein-Barr Virus, Familial Adenomatous Polyposis, Fanconi Anemia, Fibrosis, Gastroesophageal Reflux Disease, GERD, Glaucoma, Glycogen Storage Disease, Gout, Gonadal Dysfunction, Gorlin Syndrome, H. pylori Infection, Hashimoto's Thyroiditis, Headache, Heart Disease, Hemihypertrophy, Hemorrhagic Cystitis, Hepatitis, Hepatitis A Infection, Hepatitis B Infection, Hepatitis C Infection, Chronic Hepatitis, Hereditary Non-polyposis Colon Cancer, Herpes, High Grade Liver Dysplastic Nodule, HIV / AIDS, Human Papillomavirus Infection, HUS/TTP, Hypercholesterolemia, Hypercalcemia, Hyperglycemia, Hyperlipidemia, Hypertension, Hypospadias, Hypothyroidism, Inflammatory Bowel Disease, Insulin Controlled Diabetes, Interstitial Pneumontis or ARDS, Intraductal Papillary Mucinous Neoplasm, Iron Overload, Ischemic Heart Disease, ITP, Joint Replacement, Kidney Disease, Liver Cirrhosis (Liver Disease), Liver Toxicity (Non-Infectious), Li-Fraumeni Syndrome, Low Grade Liver Dysplastic Nodule, Lupus, Lynch Syndrome, MAI, Myasthenia Gravis, Myocardial Infarction, Neuroendocrine Tumor, Nonalcoholic Steatohepatitis, Obesity, Organ transplant (site), Osteoarthritis, Osteoporosis or Osteopenia, Other, Other Cancer Within 5 Years, Other Nonmalignant Systemic Disease, Other Pulmonary Complications, Pancreatitis, Pain (Various), Peptic Ulcer (Ulcer), Peripheral Neuropathy, Peripheral Vascular Disease, Peutz-Jeghers Disease, Pregnancy in Patient or Partner, Primary Sclerosing Cholangitis, Psoriasis, Pulmonary Fibrosis, Pulmonary Hemorrhage, Renal Failure (Requiring Dialysis), Renal Dialysis, Renal Insufficiency, Rheumatologic Disease, Rheumatoid Arthritis, Rubinstein-Taybi Syndrome, Sarcoidosis, Seizure, Sleep apnea, Smoking, Steatosis, Stroke, Transient Ischemic Attack, Tuberculosis, Turcot Syndrome, Tyrosinemia, Ulcerative Colitis, Wagr Syndrome, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2970715&version=1.0,
Comorbidity Method of Diagnosis,The text term used to describe the method used to diagnose the patient's comorbidity disease.,"Histology, Pathology, Radiology, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6142386&version=1.0,
Days to Adverse Event,Number of days between the date used for index and the date of the patient's adverse event.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154728&version=1.0,
Days to Comorbidity,Number of days between the date used for index and the date the patient was diagnosed with a comorbidity.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154729&version=1.0,
Days to Progression,Number of days between the date used for index and the date the patient's disease progressed.,,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154730&version=1.0,
Days to Progression Free,Number of days between the date used for index and the date the patient's disease was formally confirmed as progression-free.,,,,FALSE,Diagnosis,,,
Days to Recurrence,Number of days between the date used for index and the date the patient's disease recurred.,,,,TRUE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154731&version=1.0,
Diabetes Treatment Type,Text term used to describe the types of treatment used to manage diabetes.,"Alpha-Glucosidase Inhibitor, Biguanide, Diet, Injected Insulin, Insulin, Oral Hypoglycemic, Sulfonylurea, Thiazolidinedione, Other, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3587247&version=1.0,
Disease Response,Code assigned to describe the patient's response or outcome to the disease.,"AJ-Adjuvant Therapy, BED-Biochemical Evidence of Disease, CPD-Clinical Progression, CR-Complete Response, CRU-Complete Response Unconfirmed, DU-Disease Unchanged, IMR-Immunoresponse, IPD-Immunoprogression, MR-Minimal/Marginal response, MX-Mixed Response, Non-CR/Non-PD-Non-CR/Non-PD, NPB-No Palliative Benefit, NR-No Response, PA-Palliative Therapy, PB-Palliative Benefit, PD-Progressive Disease, PDM-Persistent Distant Metastasis, PLD-Persistent Locoregional Disease, PPD-Pseudoprogression, PR-Partial Response, PSR-Pseudoresponse, RD-Responsive Disease, RP-Response, RPD-Radiographic Progressive Disease, sCR-Stringent Complete Response, SD-Stable Disease, SPD-Surgical Progression, TE-Too Early, TF-Tumor Free, VGPR-Very Good Partial Response, WT-With Tumor, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5750671&version=1.0,
DLCO Ref Predictive Percent,"The value, as a percentage of predicted lung volume, measuring the amount of carbon monoxide detected in a patient's lungs.",,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2180255&version=1.0,
ECOG Performance Status,The ECOG functional performance status of the patient/participant.,"""0"", ""1"", ""2"", ""3"", ""4"", ""5"", Unknown, Not Reported",,"""0"", ""1"", ""2"", ""3"", ""4"", ""5""",FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=88&version=5.1,
FEV1 FVC Post Bronch Percent,Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) post-bronchodilator.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3302956&version=1.0,
FEV 1 FVC Pre Bronch Percent,Percentage value to represent result of Forced Expiratory Volume in 1 second (FEV1) divided by the Forced Vital Capacity (FVC) pre-bronchodilator.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3302955&version=1.0,
FEV1 Ref Post Bronch Percent,The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second post-bronchodilator.,,,,FALSE,Follow Up,,"https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3302948&version=1.0""",
FEV1 Ref Pre Bronch Percent,The percentage comparison to a normal value reference range of the volume of air that a patient can forcibly exhale from the lungs in one second pre-bronchodilator.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3302947&version=1.0,
Height,The height of the patient in centimeters.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=649&version=4.1,
Hepatitis Sustained Virological Response,The yes/no/unknown indicator used to describe whether the patient received treatment for a risk factor the patient had at the time of or prior to their diagnosis.,"Yes, No, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6423783&version=1.0,
HPV Positive Type,Text classification to represent the strain or type of human papillomavirus identified in an individual.,"""16"", ""18"", ""26"", ""31"", ""33"", ""35"", ""39"", ""45"", ""51"", ""52"", ""53"", ""56"", ""58"", ""59"", ""63"", ""66"", ""68"", ""70"", ""73"", ""82"", Other, Unknown, Not Reported",,"""16"", ""18"", ""26"", ""31"", ""33"", ""35"", ""39"", ""45"", ""51"", ""52"", ""53"", ""56"", ""58"", ""59"", ""63"", ""66"", ""68"", ""70"", ""73"", ""82""",FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2922649&version=1.0,
Karnofsky Performance Status,Text term used to describe the classification used of the functional capabilities of a person.,"""0"", ""10"", ""20"", ""30"", ""40"", ""50"", ""60"", ""70"", ""80"", ""90"", ""100"", Unknown, Not Reported",,"""0"", ""10"", ""20"", ""30"", ""40"", ""50"", ""60"", ""70"", ""80"", ""90"", ""100""",FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2003853&version=4.2,
Menopause Status,Text term used to describe the patient's menopause status.,"Premenopausal, Perimenopausal, Postmenopausal, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2434914&version=1.1,
Progression or Recurrence,Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.,"Yes - Progression or Recurrence, No, Unknown, Not Reported",,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3121376&version=1.0,
Yes - Progression or Recurrence,The patient has had a new tumor event after initial treatment,,"Progression or Recurrence Type, Days to Progression, Days to Progression Free, Days to Recurrence, Days to Recurrence, Progression or Recurrence Anatomic Site",,FALSE,Diagnosis,,,
Progression or Recurrence Anatomic Site,The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment,"Abdomen NOS,Abdominal esophagus,Accessory sinus NOS,Acoustic nerve,Adrenal gland NOS,Ampulla of Vater,Anal canal,Anterior 2/3 of tongue NOS,Anterior floor of mouth,Anterior mediastinum,Anterior surface of epiglottis,Anterior wall of bladder,Anterior wall of nasopharynx,Anus NOS,Aortic body and other paraganglia,Appendix,Ascending colon,Autonomic nervous system NOS,Axillary tail of breast,Base of tongue NOS,Bladder neck,Bladder NOS,Blood,Body of pancreas,Body of penis,Body of stomach,Bone marrow,Bone of limb NOS,Bone NOS,Bones of skull and face and associated joints,Border of tongue,Brain stem,Brain NOS,Branchial cleft,Breast NOS,Broad ligament,Cardia NOS,Carotid body,Cauda equina,Cecum,Central portion of breast,Cerebellum NOS,Cerebral meninges,Cerebrum,Cervical esophagus,Cervix uteri,Choroid,Ciliary body,Cloacogenic zone,Colon NOS,Commissure of lip,Conjunctiva,Connective subcutaneous and other soft tissues of abdomen,Connective subcutaneous and other soft tissues of head face and neck,Connective subcutaneous and other soft tissues of lower limb and hip,Connective subcutaneous and other soft tissues of pelvis,Connective subcutaneous and other soft tissues of thorax,Connective subcutaneous and other soft tissues of trunk NOS,Connective subcutaneous and other soft tissues of upper limb and shoulder,Connective subcutaneous and other soft tissues NOS,Cornea NOS,Corpus uteri,Cortex of adrenal gland,Cranial nerve NOS,Craniopharyngeal duct,Descended testis,Descending colon,Dome of bladder,Dorsal surface of tongue NOS,Duodenum,Endocervix,Endocrine gland NOS,Endometrium,Epididymis,Esophagus NOS,Ethmoid sinus,Exocervix,External ear,External lip NOS,External lower lip,External upper lip,Extrahepatic bile duct,Eye NOS,Eyelid,Fallopian tube,Female genital tract NOS,Floor of mouth NOS,Frontal lobe,Frontal sinus,Fundus of stomach,Fundus uteri,Gallbladder,Gastric antrum,Gastrointestinal tract NOS,Glans penis,Glottis,Greater curvature of stomach NOS,Gum NOS,Hard palate,Head of pancreas,Head face or neck NOS,Heart,Hematopoietic system NOS,Hepatic flexure of colon,Hypopharyngeal aspect of aryepiglottic fold,Hypopharynx NOS,Ileum,Ill-defined sites within respiratory system,Intestinal tract NOS,Intra-abdominal lymph nodes,Intrahepatic bile duct,Intrathoracic lymph nodes,Islets of Langerhans,Isthmus uteri,Jejunum,Kidney NOS,Labium majus,Labium minus,Lacrimal gland,Laryngeal cartilage,Larynx NOS,Lateral floor of mouth,Lateral wall of bladder,Lateral wall of nasopharynx,Lateral wall of oropharynx,Lesser curvature of stomach NOS,Lingual tonsil,Lip NOS,Liver,Long bones of lower limb and associated joints,Long bones of upper limb scapula and associated joints,Lower gum,Lower limb NOS,Lower lobe lung,Lower third of esophagus,Lower-inner quadrant of breast,Lower-outer quadrant of breast,Lung NOS,Lymph node NOS,Lymph nodes of axilla or arm,Lymph nodes of head face and neck,Lymph nodes of inguinal region or leg,Lymph nodes of multiple regions,Main bronchus,Major salivary gland NOS,Male genital organs NOS,Mandible,Maxillary sinus,Meckel diverticulum,Mediastinum NOS,Medulla of adrenal gland,Meninges NOS,Middle ear,Middle lobe lung,Middle third of esophagus,Mouth NOS,Mucosa of lip NOS,Mucosa of lower lip,Mucosa of upper lip,Myometrium,Nasal cavity,Nasopharynx NOS,Nervous system NOS,Nipple,Occipital lobe,Olfactory nerve,Optic nerve,Orbit NOS,Oropharynx NOS,Other ill-defined sites,Other specified parts of female genital organs,Other specified parts of male genital organs,Other specified parts of pancreas,Ovary,Overlapping lesion of accessory sinuses,Overlapping lesion of bladder,Overlapping lesion of bones joints and articular cartilage,Overlapping lesion of bones joints and articular cartilage of limbs,Overlapping lesion of brain,Overlapping lesion of brain and central nervous system,Overlapping lesion of breast,Overlapping lesion of cervix uteri,Overlapping lesion of colon,Overlapping lesion of connective subcutaneous and other soft tissues,Overlapping lesion of corpus uteri,Overlapping lesion of digestive system,Overlapping lesion of endocrine glands and related structures,Overlapping lesion of esophagus,Overlapping lesion of eye and adnexa,Overlapping lesion of female genital organs,Overlapping lesion of floor of mouth,Overlapping lesion of heart mediastinum and pleura,Overlapping lesion of hypopharynx,Overlapping lesion of ill-defined sites,Overlapping lesion of larynx,Overlapping lesion of lip,Overlapping lesion of lip oral cavity and pharynx,Overlapping lesion of lung,Overlapping lesion of major salivary glands,Overlapping lesion of male genital organs,Overlapping lesion of nasopharynx,Overlapping lesion of other and unspecified parts of mouth,Overlapping lesion of palate,Overlapping lesion of pancreas,Overlapping lesion of penis,Overlapping lesion of peripheral nerves and autonomic nervous system,Overlapping lesion of rectum anus and anal canal,Overlapping lesion of respiratory system and intrathoracic organs,Overlapping lesion of retroperitoneum and peritoneum,Overlapping lesion of skin,Overlapping lesion of small intestine,Overlapping lesion of stomach,Overlapping lesion of tongue,Overlapping lesion of tonsil,Overlapping lesion of urinary organs,Overlapping lesion of vulva,Overlapping lesions of oropharynx,Palate NOS,Pancreas NOS,Pancreatic duct,Parametrium,Parathyroid gland,Paraurethral gland,Parietal lobe,Parotid gland,Pelvic bones sacrum coccyx and associated joints,Pelvic lymph nodes,Pelvis NOS,Penis NOS,Peripheral nerves and autonomic nervous system of abdomen,Peripheral nerves and autonomic nervous system of head face and neck,Peripheral nerves and autonomic nervous system of lower limb and hip,Peripheral nerves and autonomic nervous system of pelvis,Peripheral nerves and autonomic nervous system of thorax,Peripheral nerves and autonomic nervous system of trunk NOS,Peripheral nerves and autonomic nervous system of upper limb and shoulder,Peritoneum NOS,Pharynx NOS,Pineal gland,Pituitary gland,Placenta,Pleura NOS,Postcricoid region,Posterior mediastinum,Posterior wall of bladder,Posterior wall of hypopharynx,Posterior wall of nasopharynx,Posterior wall of oropharynx,Prepuce,Prostate gland,Pylorus,Pyriform sinus,Rectosigmoid junction,Rectum NOS,Renal pelvis,Reticuloendothelial system NOS,Retina,Retromolar area,Retroperitoneum,Rib sternum clavicle and associated joints,Round ligament,Scrotum NOS,Short bones of lower limb and associated joints,Short bones of upper limb and associated joints,Sigmoid colon,Skin of lip NOS,Skin of lower limb and hip,Skin of other and unspecified parts of face,Skin of scalp and neck,Skin of trunk,Skin of upper limb and shoulder,Skin NOS,Small intestine NOS,Soft palate NOS,Specified parts of peritoneum,Spermatic cord,Sphenoid sinus,Spinal cord,Spinal meninges,Spleen,Splenic flexure of colon,Stomach NOS,Subglottis,Sublingual gland,Submandibular gland,Superior wall of nasopharynx,Supraglottis,Tail of pancreas,Temporal lobe,Testis NOS,Thoracic esophagus,Thorax NOS,Thymus,Thyroid gland,Tongue NOS,Tonsil NOS,Tonsillar fossa,Tonsillar pillar,Trachea,Transverse colon,Trigone of bladder,Undescended testis,Unknown primary site,Upper gum,Upper limb NOS,Upper lobe lung,Upper respiratory tract NOS,Upper third of esophagus,Upper-inner quadrant of breast,Upper-outer quadrant of breast,Urachus,Ureter,Ureteric orifice,Urethra,Urinary system NOS,Uterine adnexa,Uterus NOS,Uvula,Vagina NOS,Vallecula,Ventral surface of tongue NOS,Ventricle NOS,Vertebral column,Vestibule of mouth,Vulva NOS,Waldeyer ring,Biliary tract NOS,Cheek mucosa,Clitoris,Overlapping lesion of biliary tract,Unknown,Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161026&version=1.0,
Anatomic Site,The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment,"Abdomen NOS,Abdominal esophagus,Accessory sinus NOS,Acoustic nerve,Adrenal gland NOS,Ampulla of Vater,Anal canal,Anterior 2/3 of tongue NOS,Anterior floor of mouth,Anterior mediastinum,Anterior surface of epiglottis,Anterior wall of bladder,Anterior wall of nasopharynx,Anus NOS,Aortic body and other paraganglia,Appendix,Ascending colon,Autonomic nervous system NOS,Axillary tail of breast,Base of tongue NOS,Bladder neck,Bladder NOS,Blood,Body of pancreas,Body of penis,Body of stomach,Bone marrow,Bone of limb NOS,Bone NOS,Bones of skull and face and associated joints,Border of tongue,Brain stem,Brain NOS,Branchial cleft,Breast NOS,Broad ligament,Cardia NOS,Carotid body,Cauda equina,Cecum,Central portion of breast,Cerebellum NOS,Cerebral meninges,Cerebrum,Cervical esophagus,Cervix uteri,Choroid,Ciliary body,Cloacogenic zone,Colon NOS,Commissure of lip,Conjunctiva,Connective subcutaneous and other soft tissues of abdomen,Connective subcutaneous and other soft tissues of head face and neck,Connective subcutaneous and other soft tissues of lower limb and hip,Connective subcutaneous and other soft tissues of pelvis,Connective subcutaneous and other soft tissues of thorax,Connective subcutaneous and other soft tissues of trunk NOS,Connective subcutaneous and other soft tissues of upper limb and shoulder,Connective subcutaneous and other soft tissues NOS,Cornea NOS,Corpus uteri,Cortex of adrenal gland,Cranial nerve NOS,Craniopharyngeal duct,Descended testis,Descending colon,Dome of bladder,Dorsal surface of tongue NOS,Duodenum,Endocervix,Endocrine gland NOS,Endometrium,Epididymis,Esophagus NOS,Ethmoid sinus,Exocervix,External ear,External lip NOS,External lower lip,External upper lip,Extrahepatic bile duct,Eye NOS,Eyelid,Fallopian tube,Female genital tract NOS,Floor of mouth NOS,Frontal lobe,Frontal sinus,Fundus of stomach,Fundus uteri,Gallbladder,Gastric antrum,Gastrointestinal tract NOS,Glans penis,Glottis,Greater curvature of stomach NOS,Gum NOS,Hard palate,Head of pancreas,Head face or neck NOS,Heart,Hematopoietic system NOS,Hepatic flexure of colon,Hypopharyngeal aspect of aryepiglottic fold,Hypopharynx NOS,Ileum,Ill-defined sites within respiratory system,Intestinal tract NOS,Intra-abdominal lymph nodes,Intrahepatic bile duct,Intrathoracic lymph nodes,Islets of Langerhans,Isthmus uteri,Jejunum,Kidney NOS,Labium majus,Labium minus,Lacrimal gland,Laryngeal cartilage,Larynx NOS,Lateral floor of mouth,Lateral wall of bladder,Lateral wall of nasopharynx,Lateral wall of oropharynx,Lesser curvature of stomach NOS,Lingual tonsil,Lip NOS,Liver,Long bones of lower limb and associated joints,Long bones of upper limb scapula and associated joints,Lower gum,Lower limb NOS,Lower lobe lung,Lower third of esophagus,Lower-inner quadrant of breast,Lower-outer quadrant of breast,Lung NOS,Lymph node NOS,Lymph nodes of axilla or arm,Lymph nodes of head face and neck,Lymph nodes of inguinal region or leg,Lymph nodes of multiple regions,Main bronchus,Major salivary gland NOS,Male genital organs NOS,Mandible,Maxillary sinus,Meckel diverticulum,Mediastinum NOS,Medulla of adrenal gland,Meninges NOS,Middle ear,Middle lobe lung,Middle third of esophagus,Mouth NOS,Mucosa of lip NOS,Mucosa of lower lip,Mucosa of upper lip,Myometrium,Nasal cavity,Nasopharynx NOS,Nervous system NOS,Nipple,Occipital lobe,Olfactory nerve,Optic nerve,Orbit NOS,Oropharynx NOS,Other ill-defined sites,Other specified parts of female genital organs,Other specified parts of male genital organs,Other specified parts of pancreas,Ovary,Overlapping lesion of accessory sinuses,Overlapping lesion of bladder,Overlapping lesion of bones joints and articular cartilage,Overlapping lesion of bones joints and articular cartilage of limbs,Overlapping lesion of brain,Overlapping lesion of brain and central nervous system,Overlapping lesion of breast,Overlapping lesion of cervix uteri,Overlapping lesion of colon,Overlapping lesion of connective subcutaneous and other soft tissues,Overlapping lesion of corpus uteri,Overlapping lesion of digestive system,Overlapping lesion of endocrine glands and related structures,Overlapping lesion of esophagus,Overlapping lesion of eye and adnexa,Overlapping lesion of female genital organs,Overlapping lesion of floor of mouth,Overlapping lesion of heart mediastinum and pleura,Overlapping lesion of hypopharynx,Overlapping lesion of ill-defined sites,Overlapping lesion of larynx,Overlapping lesion of lip,Overlapping lesion of lip oral cavity and pharynx,Overlapping lesion of lung,Overlapping lesion of major salivary glands,Overlapping lesion of male genital organs,Overlapping lesion of nasopharynx,Overlapping lesion of other and unspecified parts of mouth,Overlapping lesion of palate,Overlapping lesion of pancreas,Overlapping lesion of penis,Overlapping lesion of peripheral nerves and autonomic nervous system,Overlapping lesion of rectum anus and anal canal,Overlapping lesion of respiratory system and intrathoracic organs,Overlapping lesion of retroperitoneum and peritoneum,Overlapping lesion of skin,Overlapping lesion of small intestine,Overlapping lesion of stomach,Overlapping lesion of tongue,Overlapping lesion of tonsil,Overlapping lesion of urinary organs,Overlapping lesion of vulva,Overlapping lesions of oropharynx,Palate NOS,Pancreas NOS,Pancreatic duct,Parametrium,Parathyroid gland,Paraurethral gland,Parietal lobe,Parotid gland,Pelvic bones sacrum coccyx and associated joints,Pelvic lymph nodes,Pelvis NOS,Penis NOS,Peripheral nerves and autonomic nervous system of abdomen,Peripheral nerves and autonomic nervous system of head face and neck,Peripheral nerves and autonomic nervous system of lower limb and hip,Peripheral nerves and autonomic nervous system of pelvis,Peripheral nerves and autonomic nervous system of thorax,Peripheral nerves and autonomic nervous system of trunk NOS,Peripheral nerves and autonomic nervous system of upper limb and shoulder,Peritoneum NOS,Pharynx NOS,Pineal gland,Pituitary gland,Placenta,Pleura NOS,Postcricoid region,Posterior mediastinum,Posterior wall of bladder,Posterior wall of hypopharynx,Posterior wall of nasopharynx,Posterior wall of oropharynx,Prepuce,Prostate gland,Pylorus,Pyriform sinus,Rectosigmoid junction,Rectum NOS,Renal pelvis,Reticuloendothelial system NOS,Retina,Retromolar area,Retroperitoneum,Rib sternum clavicle and associated joints,Round ligament,Scrotum NOS,Short bones of lower limb and associated joints,Short bones of upper limb and associated joints,Sigmoid colon,Skin of lip NOS,Skin of lower limb and hip,Skin of other and unspecified parts of face,Skin of scalp and neck,Skin of trunk,Skin of upper limb and shoulder,Skin NOS,Small intestine NOS,Soft palate NOS,Specified parts of peritoneum,Spermatic cord,Sphenoid sinus,Spinal cord,Spinal meninges,Spleen,Splenic flexure of colon,Stomach NOS,Subglottis,Sublingual gland,Submandibular gland,Superior wall of nasopharynx,Supraglottis,Tail of pancreas,Temporal lobe,Testis NOS,Thoracic esophagus,Thorax NOS,Thymus,Thyroid gland,Tongue NOS,Tonsil NOS,Tonsillar fossa,Tonsillar pillar,Trachea,Transverse colon,Trigone of bladder,Undescended testis,Unknown primary site,Upper gum,Upper limb NOS,Upper lobe lung,Upper respiratory tract NOS,Upper third of esophagus,Upper-inner quadrant of breast,Upper-outer quadrant of breast,Urachus,Ureter,Ureteric orifice,Urethra,Urinary system NOS,Uterine adnexa,Uterus NOS,Uvula,Vagina NOS,Vallecula,Ventral surface of tongue NOS,Ventricle NOS,Vertebral column,Vestibule of mouth,Vulva NOS,Waldeyer ring,Biliary tract NOS,Cheek mucosa,Clitoris,Overlapping lesion of biliary tract,Unknown,Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161026&version=1.0,
Treatment Anatomic Site,The text term used to describe the anatomic site of resection; biopsy; tissue or organ of biospecimen origin; progression or recurrent disease; treatment,"Abdomen NOS,Abdominal esophagus,Accessory sinus NOS,Acoustic nerve,Adrenal gland NOS,Ampulla of Vater,Anal canal,Anterior 2/3 of tongue NOS,Anterior floor of mouth,Anterior mediastinum,Anterior surface of epiglottis,Anterior wall of bladder,Anterior wall of nasopharynx,Anus NOS,Aortic body and other paraganglia,Appendix,Ascending colon,Autonomic nervous system NOS,Axillary tail of breast,Base of tongue NOS,Bladder neck,Bladder NOS,Blood,Body of pancreas,Body of penis,Body of stomach,Bone marrow,Bone of limb NOS,Bone NOS,Bones of skull and face and associated joints,Border of tongue,Brain stem,Brain NOS,Branchial cleft,Breast NOS,Broad ligament,Cardia NOS,Carotid body,Cauda equina,Cecum,Central portion of breast,Cerebellum NOS,Cerebral meninges,Cerebrum,Cervical esophagus,Cervix uteri,Choroid,Ciliary body,Cloacogenic zone,Colon NOS,Commissure of lip,Conjunctiva,Connective subcutaneous and other soft tissues of abdomen,Connective subcutaneous and other soft tissues of head face and neck,Connective subcutaneous and other soft tissues of lower limb and hip,Connective subcutaneous and other soft tissues of pelvis,Connective subcutaneous and other soft tissues of thorax,Connective subcutaneous and other soft tissues of trunk NOS,Connective subcutaneous and other soft tissues of upper limb and shoulder,Connective subcutaneous and other soft tissues NOS,Cornea NOS,Corpus uteri,Cortex of adrenal gland,Cranial nerve NOS,Craniopharyngeal duct,Descended testis,Descending colon,Dome of bladder,Dorsal surface of tongue NOS,Duodenum,Endocervix,Endocrine gland NOS,Endometrium,Epididymis,Esophagus NOS,Ethmoid sinus,Exocervix,External ear,External lip NOS,External lower lip,External upper lip,Extrahepatic bile duct,Eye NOS,Eyelid,Fallopian tube,Female genital tract NOS,Floor of mouth NOS,Frontal lobe,Frontal sinus,Fundus of stomach,Fundus uteri,Gallbladder,Gastric antrum,Gastrointestinal tract NOS,Glans penis,Glottis,Greater curvature of stomach NOS,Gum NOS,Hard palate,Head of pancreas,Head face or neck NOS,Heart,Hematopoietic system NOS,Hepatic flexure of colon,Hypopharyngeal aspect of aryepiglottic fold,Hypopharynx NOS,Ileum,Ill-defined sites within respiratory system,Intestinal tract NOS,Intra-abdominal lymph nodes,Intrahepatic bile duct,Intrathoracic lymph nodes,Islets of Langerhans,Isthmus uteri,Jejunum,Kidney NOS,Labium majus,Labium minus,Lacrimal gland,Laryngeal cartilage,Larynx NOS,Lateral floor of mouth,Lateral wall of bladder,Lateral wall of nasopharynx,Lateral wall of oropharynx,Lesser curvature of stomach NOS,Lingual tonsil,Lip NOS,Liver,Long bones of lower limb and associated joints,Long bones of upper limb scapula and associated joints,Lower gum,Lower limb NOS,Lower lobe lung,Lower third of esophagus,Lower-inner quadrant of breast,Lower-outer quadrant of breast,Lung NOS,Lymph node NOS,Lymph nodes of axilla or arm,Lymph nodes of head face and neck,Lymph nodes of inguinal region or leg,Lymph nodes of multiple regions,Main bronchus,Major salivary gland NOS,Male genital organs NOS,Mandible,Maxillary sinus,Meckel diverticulum,Mediastinum NOS,Medulla of adrenal gland,Meninges NOS,Middle ear,Middle lobe lung,Middle third of esophagus,Mouth NOS,Mucosa of lip NOS,Mucosa of lower lip,Mucosa of upper lip,Myometrium,Nasal cavity,Nasopharynx NOS,Nervous system NOS,Nipple,Occipital lobe,Olfactory nerve,Optic nerve,Orbit NOS,Oropharynx NOS,Other ill-defined sites,Other specified parts of female genital organs,Other specified parts of male genital organs,Other specified parts of pancreas,Ovary,Overlapping lesion of accessory sinuses,Overlapping lesion of bladder,Overlapping lesion of bones joints and articular cartilage,Overlapping lesion of bones joints and articular cartilage of limbs,Overlapping lesion of brain,Overlapping lesion of brain and central nervous system,Overlapping lesion of breast,Overlapping lesion of cervix uteri,Overlapping lesion of colon,Overlapping lesion of connective subcutaneous and other soft tissues,Overlapping lesion of corpus uteri,Overlapping lesion of digestive system,Overlapping lesion of endocrine glands and related structures,Overlapping lesion of esophagus,Overlapping lesion of eye and adnexa,Overlapping lesion of female genital organs,Overlapping lesion of floor of mouth,Overlapping lesion of heart mediastinum and pleura,Overlapping lesion of hypopharynx,Overlapping lesion of ill-defined sites,Overlapping lesion of larynx,Overlapping lesion of lip,Overlapping lesion of lip oral cavity and pharynx,Overlapping lesion of lung,Overlapping lesion of major salivary glands,Overlapping lesion of male genital organs,Overlapping lesion of nasopharynx,Overlapping lesion of other and unspecified parts of mouth,Overlapping lesion of palate,Overlapping lesion of pancreas,Overlapping lesion of penis,Overlapping lesion of peripheral nerves and autonomic nervous system,Overlapping lesion of rectum anus and anal canal,Overlapping lesion of respiratory system and intrathoracic organs,Overlapping lesion of retroperitoneum and peritoneum,Overlapping lesion of skin,Overlapping lesion of small intestine,Overlapping lesion of stomach,Overlapping lesion of tongue,Overlapping lesion of tonsil,Overlapping lesion of urinary organs,Overlapping lesion of vulva,Overlapping lesions of oropharynx,Palate NOS,Pancreas NOS,Pancreatic duct,Parametrium,Parathyroid gland,Paraurethral gland,Parietal lobe,Parotid gland,Pelvic bones sacrum coccyx and associated joints,Pelvic lymph nodes,Pelvis NOS,Penis NOS,Peripheral nerves and autonomic nervous system of abdomen,Peripheral nerves and autonomic nervous system of head face and neck,Peripheral nerves and autonomic nervous system of lower limb and hip,Peripheral nerves and autonomic nervous system of pelvis,Peripheral nerves and autonomic nervous system of thorax,Peripheral nerves and autonomic nervous system of trunk NOS,Peripheral nerves and autonomic nervous system of upper limb and shoulder,Peritoneum NOS,Pharynx NOS,Pineal gland,Pituitary gland,Placenta,Pleura NOS,Postcricoid region,Posterior mediastinum,Posterior wall of bladder,Posterior wall of hypopharynx,Posterior wall of nasopharynx,Posterior wall of oropharynx,Prepuce,Prostate gland,Pylorus,Pyriform sinus,Rectosigmoid junction,Rectum NOS,Renal pelvis,Reticuloendothelial system NOS,Retina,Retromolar area,Retroperitoneum,Rib sternum clavicle and associated joints,Round ligament,Scrotum NOS,Short bones of lower limb and associated joints,Short bones of upper limb and associated joints,Sigmoid colon,Skin of lip NOS,Skin of lower limb and hip,Skin of other and unspecified parts of face,Skin of scalp and neck,Skin of trunk,Skin of upper limb and shoulder,Skin NOS,Small intestine NOS,Soft palate NOS,Specified parts of peritoneum,Spermatic cord,Sphenoid sinus,Spinal cord,Spinal meninges,Spleen,Splenic flexure of colon,Stomach NOS,Subglottis,Sublingual gland,Submandibular gland,Superior wall of nasopharynx,Supraglottis,Tail of pancreas,Temporal lobe,Testis NOS,Thoracic esophagus,Thorax NOS,Thymus,Thyroid gland,Tongue NOS,Tonsil NOS,Tonsillar fossa,Tonsillar pillar,Trachea,Transverse colon,Trigone of bladder,Undescended testis,Unknown primary site,Upper gum,Upper limb NOS,Upper lobe lung,Upper respiratory tract NOS,Upper third of esophagus,Upper-inner quadrant of breast,Upper-outer quadrant of breast,Urachus,Ureter,Ureteric orifice,Urethra,Urinary system NOS,Uterine adnexa,Uterus NOS,Uvula,Vagina NOS,Vallecula,Ventral surface of tongue NOS,Ventricle NOS,Vertebral column,Vestibule of mouth,Vulva NOS,Waldeyer ring,Biliary tract NOS,Cheek mucosa,Clitoris,Overlapping lesion of biliary tract,Unknown,Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161026&version=1.0,
Progression or Recurrence Type,The text term used to describe the type of progressive or recurrent disease or relapsed disease.,"Biochemical, Distant, Local, Regional, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6142385&version=1.0,
Reflux Treatment Type,Text term used to describe the types of treatment used to manage gastroesophageal reflux disease (GERD).,"Antacids, H2 Blockers, Medically Treated, No Treatment, Not Applicable, Not Reported, Proton Pump Inhibitors, Surgically Treated, Unknown",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3440206&version=1.0,
Risk Factor,The text term used to describe a risk factor the patient had at the time of or prior to their diagnosis.,"Alcohol Consumption,Alcoholic Liver Disease,Allergy Animal NOS,Allergy Ant,Allergy Bee,Allergy Cat,Allergy Dairy or Lactose,Allergy Dog,Allergy Eggs,Allergy Food NOS,Allergy Fruit,Allergy Meat,Allergy Mold or Dust,Allergy Nuts,Allergy Processed Foods,Allergy Seafood,Allergy Wasp,Alpha-1 Antitrypsin Deficiency,Autoimmune Atrophic Chronic Gastritis,Barrett's Esophagus,Beckwith-Wiedemann,Behcet's Disease,Cancer,Cholelithiasis,Chronic Hepatitis,Cirrhosis,Colon Polyps,Common variable immune deficiency (CVID),Denys-Drash Syndrome,Diabetes NOS,Diabetes Type I,Diabetes Type II,Diet,Diverticulitis,Endometriosis,Endosalpingiosis,Eczema,Epstein-Barr Virus,Familial Adenomatous Polyposis,Fanconi Anemia,Fibrosis,Gastric Polyp(s),Gilbert's Syndrome,Gorlin Syndrome,Hashimoto's Thyroiditis,Hay Fever,Headache,Helicobacter Pylori-Associated Gastritis,Hematologic Disorder NOS,Hemihypertrophy,Hemochromatosis,Hepatic Encephalopathy,Hepatitis B Infection,Hepatitis C Infection,Hepatitis NOS,High Grade Dysplasia,HIV,Human Papillomavirus Infection,Hypospadias,Intestinal Metaplasia,Iron Overload,Li-Fraumeni Syndrome,Low Grade Dysplasia,Lymphocytic Thyroiditis,Lynch Syndrome,Myasthenia Gravis,Nonalcoholic Fatty Liver Disease,Nonalcoholic Steatohepatitis,Obesity,Oral Contraceptives,Pancreatitis,Parasitic Disease of Biliary Tract,Primary Sclerosing Cholangitis,Recurrent Pyogenic Cholangitis,Reflux Disease,Rheumatoid Arthritis,Rubinstein-Taybi Syndrome,Sarcoidosis,Seizure,Sensory Changes,Serous tubal intraepithelial carcinoma (STIC),Steatosis,Tattoo,Thyroid Nodular Hyperplasia,Tobacco NOS,Tobacco Smokeless,Tobacco Smoking,Turcot Syndrome,Undescended Testis,Vision Changes,Wagr Syndrome,Unknown,Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6142389&version=1.0,
Risk Factor Treatment,The yes/no/unknown indicator used to describe whether the patient received treatment for a risk factor the patient had at the time of or prior to their diagnosis.,"Yes, No, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6514356&version=1.0,
Viral Hepatitis Serologies,Text term that describes the kind of serological laboratory test used to determine the patient's hepatitus status.,"HBV Core Antibody, HBV DNA, HBV Genotype, HBV Surface Antibody, HCV Genotype, Hepatitis B Surface Antigen, Hepatitis C Antibody, Hepatitis C Virus RNA, Unknown, Not Reported",,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=4395982&version=1.0,
Weight,The weight of the patient measured in kilograms.,,,,FALSE,Follow Up,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=651&version=4.0,
Days to Treatment End,Number of days between the date used for index and the date the treatment ended.,,,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154725&version=1.0,
Days to Treatment Start,Number of days between the date used for index and the date the treatment started.,,,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154726&version=1.0,
Initial Disease Status,The text term used to describe the status of the patient's malignancy when the treatment began.,"Initial Diagnosis, Progressive Disease, Recurrent Disease, Residual Disease, Unknown, Not Reported",,,FALSE,Therapy,,,
Regimen or Line of Therapy,The text term used to describe the regimen or line of therapy.,,,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161024&version=1.0,
Therapeutic Agents,Text identification of the individual agent(s) used as part of a treatment regimen.,,,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2975232&version=1.0,
Treatment Effect,The text term used to describe the pathologic effect a treatment(s) had on the tumor.,"Complete Necrosis (No Viable Tumor), Incomplete Necrosis (Viable Tumor Present), No Necrosis, Unknown, Not Reported",,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6514354&version=1.0,
Treatment Intent Type,Text term to identify the reason for the administration of a treatment regimen. [Manually-curated],"Adjuvant, Cancer Control, Cure, Neoadjuvant, Palliative, Prevention, Unknown, Not Reported",,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2793511&version=1.0,
Treatment or Therapy,A yes/no/unknown/not applicable indicator related to the administration of therapeutic agents received.,"yes, no, unknown, not reported",,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=4231463&version=1.0,
Treatment Outcome,Text term that describes the patient's final outcome after the treatment was administered.,"Complete Response, Mixed Response, No Measurable Disease, No Response, Partial Response, Persistent Disease, Progressive Disease, Stable Disease, Treatment Ongoing, Treatment Stopped Due to Toxicity, Very Good Partial Response, Unknown, Not Reported",,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5102383&version=1.0,
Treatment Type,Text term that describes the kind of treatment administered.,"Ablation Cryo,Ablation Ethanol Injection,Ablation Microwave,Ablation NOS,Ablation Radiofrequency,Ablation Radiosurgical,Ancillary Treatment,Antiseizure Treatment,Bisphosphonate Therapy,Blinded Study Treatment Unknown,Brachytherapy High Dose,Brachytherapy Low Dose,Brachytherapy NOS,Chemoembolization,Chemoprotectant,Chemotherapy,Concurrent Chemoradiation,Cryoablation,Embolization,Ethanol Injection Ablation,External Beam Radiation,Hormone Therapy,I-131 Radiation Therapy,Internal Radiation,Immunotherapy (Including Vaccines),Isolated Limb Perfusion (ILP),Organ Transplantation,Other,Pharmaceutical Therapy NOS,Pleurodesis,Radiation 2D Conventional,Radiation 3D Conformal,Radiation Combination,Radiation Cyberknife,Radiation External Beam,Radiation Implants,Radiation Intensity-Modulated Radiotherapy,Radiation Internal,Radiation Proton Beam,Radiation Radioisotope,Radiation Stereotactic/Gamma Knife/SRS,Radiation Systemic,Radiation Therapy NOS,Radioactive Iodine Therapy,Radioembolization,Radiosensitizing Agent,Stem Cell Treatment,Stem Cell Transplantation Autologous,Stem Cell Transplantation Double Autologous,Stem Cell Transplantation Allogeneic,Stem Cell Transplantation Non-Myeloablative,Stem Cell Transplantation Syngenic,Stem Cell Transplantation Haploidentical,Stem Cell Transplantation NOS,Stereotactic Radiosurgery,Steroid Therapy,Surgery,Targeted Molecular Therapy,Unknown,Not Reported",,,FALSE,Therapy,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5102381&version=1.0,
Age at Diagnosis,Age at the time of diagnosis expressed in number of days since birth.,,,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3225640&version=2.0,
Days to Last Follow up,"Time interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days.",,,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3008273&version=1.0,
Days to Last Known Disease Status,"Time interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days.",,,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3008273&version=1.0,
Last Known Disease Status,Text term that describes the last known state or condition of an individual's neoplasm.,"Distant met recurrence/progression, Loco-regional recurrence/progression, Biochemical evidence of disease without structural correlate, Tumor free, Unknown tumor status, With tumor, Not Reported, Not Allowed To Collect, Not Applicable",,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2759550&version=1.0,
Morphology,"The third edition of the International Classification of Diseases for Oncology, published in 2000 used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs. In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains. A system of numbered categories for representation of data.","8000/0,8000/1,8000/3,8000/6,8000/9,8001/0,8001/1,8001/3,8002/3,8003/3,8004/3,8005/0,8005/3,8010/0,8010/2,8010/3,8010/6,8010/9,8011/0,8011/3,8012/3,8013/3,8014/3,8015/3,8020/3,8021/3,8022/3,8023/3,8030/3,8031/3,8032/3,8033/3,8034/3,8035/3,8040/0,8040/1,8041/3,8041/34,8042/3,8043/3,8044/3,8045/3,8046/3,8050/0,8050/2,8050/3,8051/0,8051/3,8052/0,8052/2,8052/3,8053/0,8060/0,8070/2,8070/3,8070/33,8070/6,8071/2,8071/3,8072/3,8073/3,8074/3,8075/3,8076/2,8076/3,8077/0,8077/2,8078/3,8080/2,8081/2,8082/3,8083/3,8084/3,8085/3,8086/3,8090/1,8090/3,8091/3,8092/3,8093/3,8094/3,8095/3,8096/0,8097/3,8098/3,8100/0,8101/0,8102/0,8102/3,8103/0,8110/0,8110/3,8120/0,8120/1,8120/2,8120/3,8121/0,8121/1,8121/3,8122/3,8123/3,8124/3,8130/1,8130/2,8130/3,8131/3,8140/0,8140/1,8140/2,8140/3,8140/33,8140/6,8141/3,8142/3,8143/3,8144/3,8145/3,8146/0,8147/0,8147/3,8148/0,8148/2,8149/0,8150/0,8150/1,8150/3,8151/0,8151/3,8152/1,8152/3,8153/1,8153/3,8154/3,8155/1,8155/3,8156/1,8156/3,8158/1,8160/0,8160/3,8161/0,8161/3,8162/3,8163/0,8163/2,8163/3,8170/0,8170/3,8171/3,8172/3,8173/3,8174/3,8175/3,8180/3,8190/0,8190/3,8191/0,8200/0,8200/3,8201/2,8201/3,8202/0,8204/0,8210/0,8210/2,8210/3,8211/0,8211/3,8212/0,8213/0,8213/3,8214/3,8215/3,8220/0,8220/3,8221/0,8221/3,8230/2,8230/3,8231/3,8240/1,8240/3,8241/3,8242/1,8242/3,8243/3,8244/3,8245/1,8245/3,8246/3,8247/3,8248/1,8249/3,8250/1,8250/2,8250/3,8251/0,8251/3,8252/3,8253/3,8254/3,8255/3,8256/3,8257/3,8260/0,8260/3,8261/0,8261/2,8261/3,8262/3,8263/0,8263/2,8263/3,8264/0,8265/3,8270/0,8270/3,8271/0,8272/0,8272/3,8280/0,8280/3,8281/0,8281/3,8290/0,8290/3,8300/0,8300/3,8310/0,8310/3,8311/1,8311/3,8312/3,8313/0,8313/1,8313/3,8314/3,8315/3,8316/3,8317/3,8318/3,8319/3,8320/3,8321/0,8322/0,8322/3,8323/0,8323/3,8324/0,8325/0,8330/0,8330/1,8330/3,8331/3,8332/3,8333/0,8333/3,8334/0,8335/3,8336/0,8337/3,8339/3,8340/3,8341/3,8342/3,8343/2,8343/3,8344/3,8345/3,8346/3,8347/3,8350/3,8360/1,8361/0,8370/0,8370/1,8370/3,8371/0,8372/0,8373/0,8374/0,8375/0,8380/0,8380/1,8380/2,8380/3,8381/0,8381/1,8381/3,8382/3,8383/3,8384/3,8390/0,8390/3,8391/0,8392/0,8400/0,8400/1,8400/3,8401/0,8401/3,8402/0,8402/3,8403/0,8403/3,8404/0,8405/0,8406/0,8407/0,8407/3,8408/0,8408/1,8408/3,8409/0,8409/3,8410/0,8410/3,8413/3,8420/0,8420/3,8430/1,8430/3,8440/0,8440/3,8441/0,8441/2,8441/3,8442/1,8443/0,8444/1,8450/0,8450/3,8451/1,8452/1,8452/3,8453/0,8453/2,8453/3,8454/0,8460/0,8460/2,8460/3,8461/0,8461/3,8462/1,8463/1,8470/0,8470/2,8470/3,8471/0,8471/3,8472/1,8473/1,8474/1,8474/3,8480/0,8480/1,8480/3,8480/6,8481/3,8482/3,8490/3,8490/6,8500/2,8500/3,8501/2,8501/3,8502/3,8503/0,8503/2,8503/3,8504/0,8504/2,8504/3,8505/0,8506/0,8507/2,8507/3,8508/3,8509/2,8509/3,8510/3,8512/3,8513/3,8514/3,8519/2,8520/2,8520/3,8521/1,8521/3,8522/1,8522/2,8522/3,8523/3,8524/3,8525/3,8530/3,8540/3,8541/3,8542/3,8543/3,8550/0,8550/1,8550/3,8551/3,8552/3,8560/0,8560/3,8561/0,8562/3,8570/3,8571/3,8572/3,8573/3,8574/3,8575/3,8576/3,8580/0,8580/1,8580/3,8581/1,8581/3,8582/1,8582/3,8583/1,8583/3,8584/1,8584/3,8585/1,8585/3,8586/3,8587/0,8588/3,8589/3,8590/1,8591/1,8592/1,8593/1,8594/1,8600/0,8600/3,8601/0,8602/0,8610/0,8620/1,8620/3,8621/1,8622/1,8623/1,8630/0,8630/1,8630/3,8631/0,8631/1,8631/3,8632/1,8633/1,8634/1,8634/3,8640/1,8640/3,8641/0,8642/1,8650/0,8650/1,8650/3,8660/0,8670/0,8670/3,8671/0,8680/0,8680/1,8680/3,8681/1,8682/1,8683/0,8690/1,8691/1,8692/1,8693/1,8693/3,8700/0,8700/3,8710/3,8711/0,8711/3,8712/0,8713/0,8714/3,8720/0,8720/2,8720/3,8721/3,8722/0,8722/3,8723/0,8723/3,8725/0,8726/0,8727/0,8728/0,8728/1,8728/3,8730/0,8730/3,8740/0,8740/3,8741/2,8741/3,8742/2,8742/3,8743/3,8744/3,8745/3,8746/3,8750/0,8760/0,8761/0,8761/1,8761/3,8762/1,8770/0,8770/3,8771/0,8771/3,8772/0,8772/3,8773/3,8774/3,8780/0,8780/3,8790/0,8800/0,8800/3,8800/9,8801/3,8802/3,8803/3,8804/3,8805/3,8806/3,8810/0,8810/1,8810/3,8811/0,8811/1,8811/3,8812/0,8812/3,8813/0,8813/3,8814/3,8815/0,8815/1,8815/3,8820/0,8821/1,8822/1,8823/0,8824/0,8824/1,8825/0,8825/1,8825/3,8826/0,8827/1,8830/0,8830/1,8830/3,8831/0,8832/0,8832/3,8833/3,8834/1,8835/1,8836/1,8840/0,8840/3,8841/1,8842/0,8842/3,8850/0,8850/1,8850/3,8851/0,8851/3,8852/0,8852/3,8853/3,8854/0,8854/3,8855/3,8856/0,8857/0,8857/3,8858/3,8860/0,8861/0,8862/0,8870/0,8880/0,8881/0,8890/0,8890/1,8890/3,8891/0,8891/3,8892/0,8893/0,8894/0,8894/3,8895/0,8895/3,8896/3,8897/1,8898/1,8900/0,8900/3,8901/3,8902/3,8903/0,8904/0,8905/0,8910/3,8912/3,8920/3,8921/3,8930/0,8930/3,8931/3,8932/0,8933/3,8934/3,8935/0,8935/1,8935/3,8936/0,8936/1,8936/3,8940/0,8940/3,8941/3,8950/3,8951/3,8959/0,8959/1,8959/3,8960/1,8960/3,8963/3,8964/3,8965/0,8966/0,8967/0,8970/3,8971/3,8972/3,8973/3,8974/1,8975/1,8980/3,8981/3,8982/0,8982/3,8983/0,8983/3,8990/0,8990/1,8990/3,8991/3,9000/0,9000/1,9000/3,9010/0,9011/0,9012/0,9013/0,9014/0,9014/1,9014/3,9015/0,9015/1,9015/3,9016/0,9020/0,9020/1,9020/3,9030/0,9040/0,9040/3,9041/3,9042/3,9043/3,9044/3,9045/3,9050/0,9050/3,9051/0,9051/3,9052/0,9052/3,9053/3,9054/0,9055/0,9055/1,9060/3,9061/3,9062/3,9063/3,9064/2,9064/3,9065/3,9070/3,9071/3,9072/3,9073/1,9080/0,9080/1,9080/3,9081/3,9082/3,9083/3,9084/0,9084/3,9085/3,9086/3,9090/0,9090/3,9091/1,9100/0,9100/1,9100/3,9101/3,9102/3,9103/0,9104/1,9105/3,9110/0,9110/1,9110/3,9120/0,9120/3,9121/0,9122/0,9123/0,9124/3,9125/0,9130/0,9130/1,9130/3,9131/0,9132/0,9133/1,9133/3,9135/1,9136/1,9137/3,9140/3,9141/0,9142/0,9150/0,9150/1,9150/3,9160/0,9161/0,9161/1,9170/0,9170/3,9171/0,9172/0,9173/0,9174/0,9174/1,9175/0,9180/0,9180/3,9181/3,9182/3,9183/3,9184/3,9185/3,9186/3,9187/3,9191/0,9192/3,9193/3,9194/3,9195/3,9200/0,9200/1,9210/0,9210/1,9220/0,9220/1,9220/3,9221/0,9221/3,9230/0,9230/3,9231/3,9240/3,9241/0,9242/3,9243/3,9250/1,9250/3,9251/1,9251/3,9252/0,9252/3,9260/3,9261/3,9262/0,9270/0,9270/1,9270/3,9271/0,9272/0,9273/0,9274/0,9275/0,9280/0,9281/0,9282/0,9290/0,9290/3,9300/0,9301/0,9302/0,9302/3,9310/0,9310/3,9311/0,9312/0,9320/0,9321/0,9322/0,9330/0,9330/3,9340/0,9341/1,9341/3,9342/3,9350/1,9351/1,9352/1,9360/1,9361/1,9362/3,9363/0,9364/3,9365/3,9370/3,9371/3,9372/3,9373/0,9380/3,9381/3,9382/3,9383/1,9384/1,9385/3,9390/0,9390/1,9390/3,9391/3,9392/3,9393/3,9394/1,9395/3,9396/3,9400/3,9401/3,9410/3,9411/3,9412/1,9413/0,9420/3,9421/1,9423/3,9424/3,9425/3,9430/3,9431/1,9432/1,9440/3,9441/3,9442/1,9442/3,9444/1,9445/3,9450/3,9451/3,9460/3,9470/3,9471/3,9472/3,9473/3,9474/3,9475/3,9476/3,9477/3,9478/3,9480/3,9490/0,9490/3,9491/0,9492/0,9493/0,9500/3,9501/0,9501/3,9502/0,9502/3,9503/3,9504/3,9505/1,9505/3,9506/1,9507/0,9508/3,9509/1,9510/0,9510/3,9511/3,9512/3,9513/3,9514/1,9520/3,9521/3,9522/3,9523/3,9530/0,9530/1,9530/3,9531/0,9532/0,9533/0,9534/0,9535/0,9537/0,9538/1,9538/3,9539/1,9539/3,9540/0,9540/1,9540/3,9541/0,9542/3,9550/0,9560/0,9560/1,9560/3,9561/3,9562/0,9570/0,9571/0,9571/3,9580/0,9580/3,9581/3,9582/0,9590/3,9591/3,9596/3,9597/3,9650/3,9651/3,9652/3,9653/3,9654/3,9655/3,9659/3,9661/3,9662/3,9663/3,9664/3,9665/3,9667/3,9670/3,9671/3,9673/3,9675/3,9678/3,9679/3,9680/3,9684/3,9687/3,9688/3,9689/3,9690/3,9691/3,9695/3,9698/3,9699/3,9700/3,9701/3,9702/3,9705/3,9708/3,9709/3,9712/3,9714/3,9716/3,9717/3,9718/3,9719/3,9724/3,9725/3,9726/3,9727/3,9728/3,9729/3,9731/3,9732/3,9733/3,9734/3,9735/3,9737/3,9738/3,9740/1,9740/3,9741/1,9741/3,9742/3,9750/3,9751/1,9751/3,9752/1,9753/1,9754/3,9755/3,9756/3,9757/3,9758/3,9759/3,9760/3,9761/3,9762/3,9764/3,9765/1,9766/1,9767/1,9768/1,9769/1,9800/3,9801/3,9805/3,9806/3,9807/3,9808/3,9809/3,9811/3,9812/3,9813/3,9814/3,9815/3,9816/3,9817/3,9818/3,9820/3,9823/3,9826/3,9827/3,9831/3,9832/3,9833/3,9834/3,9835/3,9836/3,9837/3,9840/3,9860/3,9861/3,9863/3,9865/3,9866/3,9867/3,9869/3,9870/3,9871/3,9872/3,9873/3,9874/3,9875/3,9876/3,9891/3,9895/3,9896/3,9897/3,9898/1,9898/3,9910/3,9911/3,9920/3,9930/3,9931/3,9940/3,9945/3,9946/3,9948/3,9950/3,9960/3,9961/3,9962/3,9963/3,9964/3,9965/3,9966/3,9967/3,9970/1,9971/1,9971/3,9975/3,9980/3,9982/3,9983/3,9984/3,9985/3,9986/3,9987/3,9989/3,9991/3,9992/3,Unknown,Not Reported, Not Applicable",,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3226275&version=1.0,
Primary Diagnosis,"Text term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).","Acinar cell carcinoma,Acute basophilic leukaemia,Acute leukemia Burkitt type,Acute leukemia NOS,Acute lymphatic leukemia,Acute lymphoblastic leukemia-lymphoma NOS,Acute lymphoblastic leukemia mature B-cell type,Acute lymphoblastic leukemia NOS,Acute lymphoblastic leukemia precursor cell type,Acute lymphocytic leukemia,Acute lymphoid leukemia,Acute myeloid leukemia minimal differentiation,Acute myeloid leukemia MLL,Acute myeloid leukemia NOS,Acute myelomonocytic leukemia,Acute promyelocytic leukemia NOS,Adenocarcinoid tumor,Adenocarcinoma combined with other types of carcinoma,Adenocarcinoma in a polyp NOS,Adenocarcinoma in adenomatous polyp,Adenocarcinoma in polypoid adenoma,Adenocarcinoma in situ in a polyp NOS,Adenocarcinoma in situ in adenomatous polyp,Adenocarcinoma in situ in tubular adenoma,Adenocarcinoma in situ mucinous,Adenocarcinoma in situ non-mucinous,Adenocarcinoma in situ NOS,Adenocarcinoma in tubular adenoma,Adenocarcinoma in villous adenoma,Adenocarcinoma of anal ducts,Adenocarcinoma of anal glands,Adenocarcinoma diffuse type,Adenocarcinoma endocervical type,Adenocarcinoma intestinal type,Adenocarcinoma metastatic NOS,Adenocarcinoma NOS,Adenocarcinoma pancreatobiliary type,Adult rhabdomyoma,Adult T-cell lymphoma,Adult T-cell lymphoma/leukemia,Astrocytoma anaplastic,Astrocytoma low grade,Astrocytoma NOS,B cell lymphoma NOS,B lymphoblastic leukemia/lymphoma with hyperdiploidy,B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL),B lymphoblastic leukemia/lymphoma NOS,B-ALL,B-cell lymphocytic leukemia/small lymphocytic lymphoma,Basal cell adenocarcinoma,Basal cell adenoma,Basal cell carcinoma NOS,Basal cell epithelioma,Basal cell tumor,Basophil adenocarcinoma,Basophil adenoma,Basophil carcinoma,Bile duct adenocarcinoma,Bile duct adenoma,Bile duct carcinoma,Bile duct cystadenocarcinoma,Bile duct cystadenoma,Bronchial adenoma carcinoid,Bronchial adenoma cylindroid,Bronchial adenoma NOS,Bronchial-associated lymphoid tissue lymphoma,Bronchio-alveolar carcinoma mixed mucinous and non-mucinous,Bronchio-alveolar carcinoma mucinous,Bronchiolar adenocarcinoma,Bronchiolar carcinoma,Bronchiolo-alveolar adenocarcinoma NOS,Bronchiolo-alveolar carcinoma Clara cell,Bronchiolo-alveolar carcinoma Clara cell and goblet cell type,Bronchiolo-alveolar carcinoma goblet cell type,Bronchiolo-alveolar carcinoma indeterminate type,Bronchiolo-alveolar carcinoma non-mucinous,Bronchiolo-alveolar carcinoma NOS,Burkitt cell leukemia,Burkitt lymphoma NOS (Includes all variants),Burkitt tumor,Burkitt-like lymphoma,c-ALL,Cancer,Capillary hemangioma,Capillary lymphangioma,Carcinoma in a polyp NOS,Carcinoma in adenomatous polyp,Carcinoma in pleomorphic adenoma,Carcinoma in situ in a polyp NOS,Carcinoma in situ in adenomatous polyp,Carcinoma in situ NOS,Carcinoma anaplastic NOS,Carcinoma diffuse type,Carcinoma intestinal type,Carcinoma metastatic NOS,Carcinoma NOS,Carcinoma undifferentiated NOS,Cementoma NOS,Central neuroblastoma,Central neurocytoma,Cerebellar liponeurocytoma,Cerebellar sarcoma NOS,Cervical intraepithelial neoplasia grade III,Cervical intraepithelial neoplasia low grade,Chondroma NOS,Chondrosarcoma grade 2/3,Chronic granulocytic leukemia BCR/ABL,Chronic granulocytic leukemia NOS,Chronic granulocytic leukemia Philadelphia chromosome (Ph1) positive,Chronic leukemia NOS,Chronic lymphatic leukemia,Chronic lymphocytic leukemia,Chronic lymphocytic leukemia B-cell type (includes all variants of BCLL),Chronic lymphoid leukemia,Chronic monocytic leukemia,Chronic myelocytic leukemia NOS,Chronic myelogenous leukemia BCR-ABL positive,Chronic myelogenous leukemia Philadelphia chromosome (Ph 1) positive,Chronic myeloid leukemia NOS,Chronic myelomonocytic leukemia in transformation,Chronic myelomonocytic leukemia NOS,Chronic myelomonocytic leukemia Type 1,Chronic myelomonocytic leukemia Type II,Chronic myeloproliferative disease NOS,Chronic myeloproliferative disorder,Chronic neutrophilic leukemia,Classical Hodgkin lymphoma lymphocyte depletion diffuse fibrosis,Classical Hodgkin lymphoma lymphocyte depletion NOS,Classical Hodgkin lymphoma lymphocyte depletion reticular,Classical Hodgkin lymphoma lymphocyte-rich,Classical Hodgkin lymphoma mixed cellularity NOS,Classical Hodgkin lymphoma nodular sclerosis cellular phase,Classical Hodgkin lymphoma nodular sclerosis grade 1,Classical Hodgkin lymphoma nodular sclerosis grade 2,Classical Hodgkin lymphoma nodular sclerosis NOS,Combined hepatocellular carcinoma and cholangiocarcinoma,Combined large cell neuroendocrine carcinoma,Combined small cell carcinoma,Combined small cell-adenocarcinoma,Combined small cell-large carcinoma,Combined small cell-squamous cell carcinoma,Combined/mixed carcinoid and adenocarcinoma,Composite Hodgkin and non-Hodgkin lymphoma,Dermal nevus,Dermatofibroma NOS,Diffuse astrocytoma IDH-mutant,Diffuse astrocytoma IDH-wildtype,Diffuse astrocytoma low grade,Diffuse large B-cell lymphoma NOS,Diffuse melanocytosis,Duct adenocarcinoma NOS,Duct adenoma NOS,Duct carcinoma desmoplastic type,Duct carcinoma NOS,Duct cell carcinoma,Ductal carcinoma in situ NOS,Ductal carcinoma NOS,Dysplastic nevus,Endometrial sarcoma NOS,Endometrioid adenocarcinoma NOS,Endometrioid adenofibroma NOS,Endometrioid adenoma NOS,Endometrioid carcinoma NOS,Eosinophil adenocarcinoma,Eosinophil adenoma,Eosinophil carcinoma,Eosinophilic granuloma,Eosinophilic leukemia,Ependymoma NOS,Epidermoid carcinoma in situ NOS,Epidermoid carcinoma NOS,Epithelial tumor benign,Epithelial tumor malignant,Esophageal glandular dysplasia (intraepithelial neoplasia) high grade,Esophageal glandular dysplasia (intraepithelial neoplasia) low grade,Esophageal intraepithelial neoplasia high grade,Esophageal squamous intraepithelial neoplasia (dysplasia) high grade,Esophageal squamous intraepithelial neoplasia (dysplasia) low grade,Ewing sarcoma,Ganglioglioma NOS,Gastrin cell tumor,Gastrin cell tumor malignant,Gastrinoma malignant,Gastrinoma NOS,Gastrointestinal stromal tumor malignant,Glioblastoma,Glioma malignant,Glioma NOS,Haemangioblastoma,Haemangiosarcoma,Hepatocarcinoma,Hepatocellular adenoma,Hepatocellular carcinoma NOS,Hepatocholangiocarcinoma,Hepatoid adenocarcinoma,Hepatoid carcinoma,Hodgkin disease NOS,Hodgkin granuloma,Hodgkin lymphoma mixed cellularity NOS,Hodgkin lymphoma nodular sclerosis NOS,Hodgkin lymphoma NOS,Hodgkin paragranuloma NOS,Hodgkin sarcoma,Infiltrating basal cell carcinoma NOS,Infiltrating duct and colloid carcinoma,Infiltrating duct and cribriform carcinoma,Inflammatory adenocarcinoma,Inflammatory carcinoma,Interstitial cell tumor benign,Interstitial cell tumor malignant,Interstitial cell tumor NOS,Intracystic papilloma,Intradermal nevus,Intraductal adenocarcinoma noninfiltrating NOS,Intraductal and lobular carcinoma,Intraductal carcinoma and lobular carcinoma in situ,Intraductal carcinoma clinging,Intraductal carcinoma noninfiltrating NOS,Intraductal carcinoma NOS,Intraductal carcinoma solid type,Intraductal micropapillary carcinoma,Intraductal papillary adenocarcinoma with invasion,Intraductal papillary adenocarcinoma NOS,Intraductal papillary carcinoma,Intraductal tubular-papillary neoplasm high grade,Intraductal tubular-papillary neoplasm low grade,Intraductal tubulopapillary neoplasm,Intraepidermal carcinoma NOS,Intraepidermal squamous cell carcinoma Bowen type,Intravascular B-cell lymphoma,Juvenile myelomonocytic leukemia,Kaposi sarcoma,Large cell carcinoma NOS,Liposarcoma differentiated,Liposarcoma NOS,Liposarcoma well differentiated,Liver cell adenoma,Liver cell carcinoma,Lobular adenocarcinoma,Lobular and ductal carcinoma,Lobular carcinoma in situ NOS,Lobular carcinoma noninfiltrating,Lobular carcinoma NOS,Lymphatic leukemic NOS,Lymphoblastic leukemia NOS,Lymphoblastoma,Lymphocytic leukemia NOS,Lymphoma NOS,Malignancy,Malignant lymphoma diffuse NOS,Malignant lymphoma Hodgkin,Malignant lymphoma immunoblastic NOS,Malignant lymphoma large B-cell diffuse NOS,Malignant lymphoma large B-cell NOS,Malignant lymphoma large cell NOS,Malignant lymphoma lymphoblastic NOS,Malignant lymphoma lymphocytic diffuse NOS,Malignant lymphoma lymphocytic nodular NOS,Malignant lymphoma lymphocytic NOS,Malignant lymphoma mixed cell type diffuse,Malignant lymphoma mixed cell type follicular,Malignant lymphoma mixed cell type nodular,Malignant lymphoma nodular NOS,Malignant lymphoma non-Hodgkin NOS,Malignant lymphoma NOS,Malignant lymphoma small B lymphocytic NOS,Malignant melanoma in congenital melanocytic nevus,Malignant melanoma in giant pigmented nevus,Malignant melanoma in Hutchinson melanotic freckle,Malignant melanoma in junctional nevus,Malignant melanoma in precancerous melanosis,Malignant melanoma NOS,Malignant melanoma regressing,Mammary carcinoma in situ,Medullary adenocarcinoma,Medullary carcinoma NOS,Medullary osteosarcoma,Medulloblastoma NOS,Melanoameloblastoma,Melanocytic nevus,Melanocytoma eyeball,Melanocytoma NOS,Melanoma in situ,Melanoma malignant of soft parts,Melanoma NOS,Melanotic medulloblastoma,Melanotic MPNST,Melanotic neuroectodermal tumor,Melanotic neurofibroma,Melanotic progonoma,Melanotic psammomatous MPNST,Melanotic schwannoma,Meningeal melanocytoma,Meningeal melanoma,Meningioma anaplastic,Meningioma malignant,Meningioma NOS,Micropapillary carcinoma NOS,Mixed adenocarcinoma and epidermoid carcinoma,Mixed adenocarcinoma and squamous cell carcinoma,Mixed medullary-follicular carcinoma,Mixed medullary-papillary carcinoma,Mixed pancreatic endocrine and exocrine tumor malignant,Mixed pineal tumor,Mixed small cell carcinoma,Mixed squamous cell and glandular papilloma,Mixed tumor malignant NOS,Mixed tumor NOS,Monocytic leukemia NOS,Mucosal-associated lymphoid tissue lymphoma,Mucous adenocarcinoma,Multiple myeloma,Myelocytic leukemia NOS,Myeloid leukemia NOS,Myeloma NOS,Myoepithelioma,Neoplasm benign,Neoplasm malignant,Neoplasm malignant uncertain whether primary or metastatic,Neoplasm metastatic,Neoplasm NOS,Neoplasm secondary,Neoplasm uncertain whether benign or malignant,Nephroblastoma NOS,Neuroendocrine carcinoma NOS,Neuroepithelioma NOS,Neurofibroma NOS,Neurofibromatosis NOS,Neurofibrosarcoma,Neurosarcoma,Nevus NOS,Non-Hodgkin lymphoma NOS,Non-invasive low grade serous carcinoma,Non-lymphocytic leukemia NOS,Non-small cell carcinoma,Nonpigmented nevus,Not Reported,Oat cell carcinoma,Osteoblastoma malignant,Osteoblastoma NOS,Osteosarcoma NOS,Paget disease and infiltrating duct carcinoma of breast,Paget disease and intraductal carcinoma of breast,Paget disease of breast,Paget disease extramammary,Paget disease mammary,Pagetoid reticulosis,Pancreatic endocrine tumor benign,Pancreatic endocrine tumor malignant,Pancreatic endocrine tumor nonfunctioning,Pancreatic endocrine tumor NOS,Pancreatic microadenoma,Pancreatobiliary neoplasm non-invasive,Pancreatobiliary-type carcinoma,Pancreatoblastoma,Papillary adenocarcinoma follicular variant,Papillary adenocarcinoma NOS,Papillary adenofibroma,Papillary adenoma NOS,Papillary and follicular carcinoma,Papillary carcinoma in situ,Papillary carcinoma NOS,Papillary cystadenoma NOS,Papillary epidermoid carcinoma,Papillary glioneuronal tumor,Papillary meningioma,Papillary microcarcinoma,Papillary renal cell carcinoma,Papillary serous adenocarcinoma,Papillary serous cystadenocarcinoma,Papillary serous cystadenoma NOS,Papillary squamous cell carcinoma,Papillary squamous cell carcinoma in situ,Papillary transitional cell carcinoma,Papillary tumor of the pineal region,Papillary urothelial carcinoma,Papilloma of bladder,Papilloma NOS,Papillomatosis glandular,Papillomatosis NOS,Papillotubular adenocarcinoma,Papillotubular adenoma,Paraganglioma benign,Paraganglioma malignant,Paraganglioma NOS,Peripheral T-cell lymphoma large cell,Peripheral T-cell lymphoma NOS,Pigmented adenoma,Pigmented basal cell carcinoma,Pigmented nevus NOS,Pituitary adenoma NOS,Pituitary carcinoma NOS,Pleomorphic adenoma,Pleomorphic carcinoma,Pleomorphic lipoma,Pleomorphic liposarcoma,Pleomorphic lobular carcinoma,Pleomorphic lobular carcinoma in situ,Precancerous melanosis NOS,Precursor B-cell lymphoblastic leukemia,Precursor B-cell lymphoblastic lymphoma,Precursor cell lymphoblastic leukemia NOS,Precursor T-cell lymphoblastic leukemia,Precursor T-cell lymphoblastic lymphoma,Preleukemia,Preleukemic syndrome,Primary amyloidosis,Pro-B ALL,Pro-T ALL,Prostatic intraepithelial neoplasia grade III,Pulmonary adenomatosis,Pulmonary artery intimal sarcoma,Pulmonary blastoma,Renal carcinoma collecting duct type,Renal cell adenocarcinoma,Renal cell carcinoma chromophobe type,Renal cell carcinoma NOS,Renal cell carcinoma sarcomatoid,Renal cell carcinoma spindle cell,Renal cell carcinoma unclassified,Renal medullary carcinoma,Rhabdoid meningioma,Rhabdoid sarcoma,Rhabdoid tumor NOS,Rhabdomyoma NOS,Rhabdomyosarcoma with ganglionic differentiation,Rhabdomyosarcoma NOS,Rhabdosarcoma,Rodent ulcer,Sarcoma NOS,Sclerosing hemangioma,Sclerosing hepatic carcinoma,Secondary carcinoma,Secretory carcinoma of breast,Skin appendage carcinoma,Small cell carcinoma NOS,Small cell neuroendocrine carcinoma,Small cell osteosarcoma,Small cell sarcoma,Small congenital nevus,Spindle cell carcinoma NOS,Spindle cell melanoma NOS,Splenic B-cell lymphoma/leukemia unclassifiable,Splenic diffuse red pulp small B-cell lymphoma,Splenic lymphoma with villous lymphocytes,Splenic marginal zone B-cell lymphoma,Splenic marginal zone lymphoma NOS,Squamous cell carcinoma in situ NOS,Squamous cell carcinoma adenoid,Squamous cell carcinoma clear cell type,Squamous cell carcinoma NOS,T lymphoblastic leukemia/lymphoma,T-cell large granular lymphocytic leukemia,T-cell large granular lymphocytosis,T-cell lymphoma NOS,Teratoma malignant NOS,Teratoma NOS,Therapy related myeloid neoplasm,Transitional carcinoma,Transitional cell carcinoma,Transitional cell carcinoma in situ,Tubular adenocarcinoma,Tubular adenoma NOS,Tubular androblastoma with lipid storage,Tubular androblastoma NOS,Tubular carcinoid,Tubular carcinoma,Tubulo-papillary adenoma,Tubulocystic renal cell carcinoma,Tubulolobular carcinoma,Tubulopapillary adenocarcinoma,Tubulovillous adenoma NOS,Tumor cells benign,Tumor cells malignant,Tumor cells NOS,Tumor cells uncertain whether benign or malignant,Tumor embolus,Tumor benign,Tumor malignant NOS,Tumor metastatic,Tumor NOS,Tumor secondary,Tumorlet benign,Typical carcinoid,Unclassified tumor benign,Unclassified tumor borderline malignancy,Unclassified tumor malignant,Unclassified tumor malignant uncertain whether primary or metastatic,Unclassified tumor uncertain whether benign or malignant,Undifferentiated epithelioid sarcoma,Undifferentiated high-grade pleomorphic sarcoma,Undifferentiated leukaemia,Undifferentiated pleomorphic sarcoma,Undifferentiated round cell sarcoma,Undifferentiated sarcoma,Undifferentiated spindle cell sarcoma,Undifferentiated uterine sarcoma,Unknown",,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161032&version=1.0,
Prior Malignancy,The yes/no/unknown indicator used to describe the patient's history of prior cancer diagnosis.,"Yes, No, Unknown, Not Reported, Not Allowed To Collect",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3382736&version=2.0,
Prior Treatment,A yes/no/unknown/not applicable indicator related to the administration of therapeutic agents received before the body specimen was collected.,"Yes, No, Unknown, Not Reported, Not Allowed To Collect",,,FALSE,Diagnosis,,,
Site of Resection or Biopsy,"The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).","Abdomen NOS,Abdominal esophagus,Accessory sinus NOS,Acoustic nerve,Adrenal gland NOS,Ampulla of Vater,Anal canal,Anterior 2/3 of tongue NOS,Anterior floor of mouth,Anterior mediastinum,Anterior surface of epiglottis,Anterior wall of bladder,Anterior wall of nasopharynx,Anus NOS,Aortic body and other paraganglia,Appendix,Ascending colon,Autonomic nervous system NOS,Axillary tail of breast,Base of tongue NOS,Bladder neck,Bladder NOS,Blood,Body of pancreas,Body of penis,Body of stomach,Bone marrow,Bone of limb NOS,Bone NOS,Bones of skull and face and associated joints,Border of tongue,Brain stem,Brain NOS,Branchial cleft,Breast NOS,Broad ligament,Cardia NOS,Carotid body,Cauda equina,Cecum,Central portion of breast,Cerebellum NOS,Cerebral meninges,Cerebrum,Cervical esophagus,Cervix uteri,Choroid,Ciliary body,Cloacogenic zone,Colon NOS,Commissure of lip,Conjunctiva,Connective subcutaneous and other soft tissues of abdomen,Connective subcutaneous and other soft tissues of head face and neck,Connective subcutaneous and other soft tissues of lower limb and hip,Connective subcutaneous and other soft tissues of pelvis,Connective subcutaneous and other soft tissues of thorax,Connective subcutaneous and other soft tissues of trunk NOS,Connective subcutaneous and other soft tissues of upper limb and shoulder,Connective subcutaneous and other soft tissues NOS,Cornea NOS,Corpus uteri,Cortex of adrenal gland,Cranial nerve NOS,Craniopharyngeal duct,Descended testis,Descending colon,Dome of bladder,Dorsal surface of tongue NOS,Duodenum,Endocervix,Endocrine gland NOS,Endometrium,Epididymis,Esophagus NOS,Ethmoid sinus,Exocervix,External ear,External lip NOS,External lower lip,External upper lip,Extrahepatic bile duct,Eye NOS,Eyelid,Fallopian tube,Female genital tract NOS,Floor of mouth NOS,Frontal lobe,Frontal sinus,Fundus of stomach,Fundus uteri,Gallbladder,Gastric antrum,Gastrointestinal tract NOS,Glans penis,Glottis,Greater curvature of stomach NOS,Gum NOS,Hard palate,Head of pancreas,Head face or neck NOS,Heart,Hematopoietic system NOS,Hepatic flexure of colon,Hypopharyngeal aspect of aryepiglottic fold,Hypopharynx NOS,Ileum,Ill-defined sites within respiratory system,Intestinal tract NOS,Intra-abdominal lymph nodes,Intrahepatic bile duct,Intrathoracic lymph nodes,Islets of Langerhans,Isthmus uteri,Jejunum,Kidney NOS,Labium majus,Labium minus,Lacrimal gland,Laryngeal cartilage,Larynx NOS,Lateral floor of mouth,Lateral wall of bladder,Lateral wall of nasopharynx,Lateral wall of oropharynx,Lesser curvature of stomach NOS,Lingual tonsil,Lip NOS,Liver,Long bones of lower limb and associated joints,Long bones of upper limb scapula and associated joints,Lower gum,Lower limb NOS,Lower lobe lung,Lower third of esophagus,Lower-inner quadrant of breast,Lower-outer quadrant of breast,Lung NOS,Lymph node NOS,Lymph nodes of axilla or arm,Lymph nodes of head face and neck,Lymph nodes of inguinal region or leg,Lymph nodes of multiple regions,Main bronchus,Major salivary gland NOS,Male genital organs NOS,Mandible,Maxillary sinus,Meckel diverticulum,Mediastinum NOS,Medulla of adrenal gland,Meninges NOS,Middle ear,Middle lobe lung,Middle third of esophagus,Mouth NOS,Mucosa of lip NOS,Mucosa of lower lip,Mucosa of upper lip,Myometrium,Nasal cavity,Nasopharynx NOS,Nervous system NOS,Nipple,Occipital lobe,Olfactory nerve,Optic nerve,Orbit NOS,Oropharynx NOS,Other ill-defined sites,Other specified parts of female genital organs,Other specified parts of male genital organs,Other specified parts of pancreas,Ovary,Overlapping lesion of accessory sinuses,Overlapping lesion of bladder,Overlapping lesion of bones joints and articular cartilage,Overlapping lesion of bones joints and articular cartilage of limbs,Overlapping lesion of brain,Overlapping lesion of brain and central nervous system,Overlapping lesion of breast,Overlapping lesion of cervix uteri,Overlapping lesion of colon,Overlapping lesion of connective subcutaneous and other soft tissues,Overlapping lesion of corpus uteri,Overlapping lesion of digestive system,Overlapping lesion of endocrine glands and related structures,Overlapping lesion of esophagus,Overlapping lesion of eye and adnexa,Overlapping lesion of female genital organs,Overlapping lesion of floor of mouth,Overlapping lesion of heart mediastinum and pleura,Overlapping lesion of hypopharynx,Overlapping lesion of ill-defined sites,Overlapping lesion of larynx,Overlapping lesion of lip,Overlapping lesion of lip oral cavity and pharynx,Overlapping lesion of lung,Overlapping lesion of major salivary glands,Overlapping lesion of male genital organs,Overlapping lesion of nasopharynx,Overlapping lesion of other and unspecified parts of mouth,Overlapping lesion of palate,Overlapping lesion of pancreas,Overlapping lesion of penis,Overlapping lesion of peripheral nerves and autonomic nervous system,Overlapping lesion of rectum anus and anal canal,Overlapping lesion of respiratory system and intrathoracic organs,Overlapping lesion of retroperitoneum and peritoneum,Overlapping lesion of skin,Overlapping lesion of small intestine,Overlapping lesion of stomach,Overlapping lesion of tongue,Overlapping lesion of tonsil,Overlapping lesion of urinary organs,Overlapping lesion of vulva,Overlapping lesions of oropharynx,Palate NOS,Pancreas NOS,Pancreatic duct,Parametrium,Parathyroid gland,Paraurethral gland,Parietal lobe,Parotid gland,Pelvic bones sacrum coccyx and associated joints,Pelvic lymph nodes,Pelvis NOS,Penis NOS,Peripheral nerves and autonomic nervous system of abdomen,Peripheral nerves and autonomic nervous system of head face and neck,Peripheral nerves and autonomic nervous system of lower limb and hip,Peripheral nerves and autonomic nervous system of pelvis,Peripheral nerves and autonomic nervous system of thorax,Peripheral nerves and autonomic nervous system of trunk NOS,Peripheral nerves and autonomic nervous system of upper limb and shoulder,Peritoneum NOS,Pharynx NOS,Pineal gland,Pituitary gland,Placenta,Pleura NOS,Postcricoid region,Posterior mediastinum,Posterior wall of bladder,Posterior wall of hypopharynx,Posterior wall of nasopharynx,Posterior wall of oropharynx,Prepuce,Prostate gland,Pylorus,Pyriform sinus,Rectosigmoid junction,Rectum NOS,Renal pelvis,Reticuloendothelial system NOS,Retina,Retromolar area,Retroperitoneum,Rib sternum clavicle and associated joints,Round ligament,Scrotum NOS,Short bones of lower limb and associated joints,Short bones of upper limb and associated joints,Sigmoid colon,Skin of lip NOS,Skin of lower limb and hip,Skin of other and unspecified parts of face,Skin of scalp and neck,Skin of trunk,Skin of upper limb and shoulder,Skin NOS,Small intestine NOS,Soft palate NOS,Specified parts of peritoneum,Spermatic cord,Sphenoid sinus,Spinal cord,Spinal meninges,Spleen,Splenic flexure of colon,Stomach NOS,Subglottis,Sublingual gland,Submandibular gland,Superior wall of nasopharynx,Supraglottis,Tail of pancreas,Temporal lobe,Testis NOS,Thoracic esophagus,Thorax NOS,Thymus,Thyroid gland,Tongue NOS,Tonsil NOS,Tonsillar fossa,Tonsillar pillar,Trachea,Transverse colon,Trigone of bladder,Undescended testis,Unknown primary site,Upper gum,Upper limb NOS,Upper lobe lung,Upper respiratory tract NOS,Upper third of esophagus,Upper-inner quadrant of breast,Upper-outer quadrant of breast,Urachus,Ureter,Ureteric orifice,Urethra,Urinary system NOS,Uterine adnexa,Uterus NOS,Uvula,Vagina NOS,Vallecula,Ventral surface of tongue NOS,Ventricle NOS,Vertebral column,Vestibule of mouth,Vulva NOS,Waldeyer ring,Biliary tract NOS,Cheek mucosa,Clitoris,Overlapping lesion of biliary tract,Unknown,Not Reported",,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161034&version=1.0,
Tissue or Organ of Origin,"The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).","Abdomen NOS,Abdominal esophagus,Accessory sinus NOS,Acoustic nerve,Adrenal gland NOS,Ampulla of Vater,Anal canal,Anterior 2/3 of tongue NOS,Anterior floor of mouth,Anterior mediastinum,Anterior surface of epiglottis,Anterior wall of bladder,Anterior wall of nasopharynx,Anus NOS,Aortic body and other paraganglia,Appendix,Ascending colon,Autonomic nervous system NOS,Axillary tail of breast,Base of tongue NOS,Bladder neck,Bladder NOS,Blood,Body of pancreas,Body of penis,Body of stomach,Bone marrow,Bone of limb NOS,Bone NOS,Bones of skull and face and associated joints,Border of tongue,Brain stem,Brain NOS,Branchial cleft,Breast NOS,Broad ligament,Cardia NOS,Carotid body,Cauda equina,Cecum,Central portion of breast,Cerebellum NOS,Cerebral meninges,Cerebrum,Cervical esophagus,Cervix uteri,Choroid,Ciliary body,Cloacogenic zone,Colon NOS,Commissure of lip,Conjunctiva,Connective subcutaneous and other soft tissues of abdomen,Connective subcutaneous and other soft tissues of head face and neck,Connective subcutaneous and other soft tissues of lower limb and hip,Connective subcutaneous and other soft tissues of pelvis,Connective subcutaneous and other soft tissues of thorax,Connective subcutaneous and other soft tissues of trunk NOS,Connective subcutaneous and other soft tissues of upper limb and shoulder,Connective subcutaneous and other soft tissues NOS,Cornea NOS,Corpus uteri,Cortex of adrenal gland,Cranial nerve NOS,Craniopharyngeal duct,Descended testis,Descending colon,Dome of bladder,Dorsal surface of tongue NOS,Duodenum,Endocervix,Endocrine gland NOS,Endometrium,Epididymis,Esophagus NOS,Ethmoid sinus,Exocervix,External ear,External lip NOS,External lower lip,External upper lip,Extrahepatic bile duct,Eye NOS,Eyelid,Fallopian tube,Female genital tract NOS,Floor of mouth NOS,Frontal lobe,Frontal sinus,Fundus of stomach,Fundus uteri,Gallbladder,Gastric antrum,Gastrointestinal tract NOS,Glans penis,Glottis,Greater curvature of stomach NOS,Gum NOS,Hard palate,Head of pancreas,Head face or neck NOS,Heart,Hematopoietic system NOS,Hepatic flexure of colon,Hypopharyngeal aspect of aryepiglottic fold,Hypopharynx NOS,Ileum,Ill-defined sites within respiratory system,Intestinal tract NOS,Intra-abdominal lymph nodes,Intrahepatic bile duct,Intrathoracic lymph nodes,Islets of Langerhans,Isthmus uteri,Jejunum,Kidney NOS,Labium majus,Labium minus,Lacrimal gland,Laryngeal cartilage,Larynx NOS,Lateral floor of mouth,Lateral wall of bladder,Lateral wall of nasopharynx,Lateral wall of oropharynx,Lesser curvature of stomach NOS,Lingual tonsil,Lip NOS,Liver,Long bones of lower limb and associated joints,Long bones of upper limb scapula and associated joints,Lower gum,Lower limb NOS,Lower lobe lung,Lower third of esophagus,Lower-inner quadrant of breast,Lower-outer quadrant of breast,Lung NOS,Lymph node NOS,Lymph nodes of axilla or arm,Lymph nodes of head face and neck,Lymph nodes of inguinal region or leg,Lymph nodes of multiple regions,Main bronchus,Major salivary gland NOS,Male genital organs NOS,Mandible,Maxillary sinus,Meckel diverticulum,Mediastinum NOS,Medulla of adrenal gland,Meninges NOS,Middle ear,Middle lobe lung,Middle third of esophagus,Mouth NOS,Mucosa of lip NOS,Mucosa of lower lip,Mucosa of upper lip,Myometrium,Nasal cavity,Nasopharynx NOS,Nervous system NOS,Nipple,Occipital lobe,Olfactory nerve,Optic nerve,Orbit NOS,Oropharynx NOS,Other ill-defined sites,Other specified parts of female genital organs,Other specified parts of male genital organs,Other specified parts of pancreas,Ovary,Overlapping lesion of accessory sinuses,Overlapping lesion of bladder,Overlapping lesion of bones joints and articular cartilage,Overlapping lesion of bones joints and articular cartilage of limbs,Overlapping lesion of brain,Overlapping lesion of brain and central nervous system,Overlapping lesion of breast,Overlapping lesion of cervix uteri,Overlapping lesion of colon,Overlapping lesion of connective subcutaneous and other soft tissues,Overlapping lesion of corpus uteri,Overlapping lesion of digestive system,Overlapping lesion of endocrine glands and related structures,Overlapping lesion of esophagus,Overlapping lesion of eye and adnexa,Overlapping lesion of female genital organs,Overlapping lesion of floor of mouth,Overlapping lesion of heart mediastinum and pleura,Overlapping lesion of hypopharynx,Overlapping lesion of ill-defined sites,Overlapping lesion of larynx,Overlapping lesion of lip,Overlapping lesion of lip oral cavity and pharynx,Overlapping lesion of lung,Overlapping lesion of major salivary glands,Overlapping lesion of male genital organs,Overlapping lesion of nasopharynx,Overlapping lesion of other and unspecified parts of mouth,Overlapping lesion of palate,Overlapping lesion of pancreas,Overlapping lesion of penis,Overlapping lesion of peripheral nerves and autonomic nervous system,Overlapping lesion of rectum anus and anal canal,Overlapping lesion of respiratory system and intrathoracic organs,Overlapping lesion of retroperitoneum and peritoneum,Overlapping lesion of skin,Overlapping lesion of small intestine,Overlapping lesion of stomach,Overlapping lesion of tongue,Overlapping lesion of tonsil,Overlapping lesion of urinary organs,Overlapping lesion of vulva,Overlapping lesions of oropharynx,Palate NOS,Pancreas NOS,Pancreatic duct,Parametrium,Parathyroid gland,Paraurethral gland,Parietal lobe,Parotid gland,Pelvic bones sacrum coccyx and associated joints,Pelvic lymph nodes,Pelvis NOS,Penis NOS,Peripheral nerves and autonomic nervous system of abdomen,Peripheral nerves and autonomic nervous system of head face and neck,Peripheral nerves and autonomic nervous system of lower limb and hip,Peripheral nerves and autonomic nervous system of pelvis,Peripheral nerves and autonomic nervous system of thorax,Peripheral nerves and autonomic nervous system of trunk NOS,Peripheral nerves and autonomic nervous system of upper limb and shoulder,Peritoneum NOS,Pharynx NOS,Pineal gland,Pituitary gland,Placenta,Pleura NOS,Postcricoid region,Posterior mediastinum,Posterior wall of bladder,Posterior wall of hypopharynx,Posterior wall of nasopharynx,Posterior wall of oropharynx,Prepuce,Prostate gland,Pylorus,Pyriform sinus,Rectosigmoid junction,Rectum NOS,Renal pelvis,Reticuloendothelial system NOS,Retina,Retromolar area,Retroperitoneum,Rib sternum clavicle and associated joints,Round ligament,Scrotum NOS,Short bones of lower limb and associated joints,Short bones of upper limb and associated joints,Sigmoid colon,Skin of lip NOS,Skin of lower limb and hip,Skin of other and unspecified parts of face,Skin of scalp and neck,Skin of trunk,Skin of upper limb and shoulder,Skin NOS,Small intestine NOS,Soft palate NOS,Specified parts of peritoneum,Spermatic cord,Sphenoid sinus,Spinal cord,Spinal meninges,Spleen,Splenic flexure of colon,Stomach NOS,Subglottis,Sublingual gland,Submandibular gland,Superior wall of nasopharynx,Supraglottis,Tail of pancreas,Temporal lobe,Testis NOS,Thoracic esophagus,Thorax NOS,Thymus,Thyroid gland,Tongue NOS,Tonsil NOS,Tonsillar fossa,Tonsillar pillar,Trachea,Transverse colon,Trigone of bladder,Undescended testis,Unknown primary site,Upper gum,Upper limb NOS,Upper lobe lung,Upper respiratory tract NOS,Upper third of esophagus,Upper-inner quadrant of breast,Upper-outer quadrant of breast,Urachus,Ureter,Ureteric orifice,Urethra,Urinary system NOS,Uterine adnexa,Uterus NOS,Uvula,Vagina NOS,Vallecula,Ventral surface of tongue NOS,Ventricle NOS,Vertebral column,Vestibule of mouth,Vulva NOS,Waldeyer ring,Biliary tract NOS,Cheek mucosa,Clitoris,Overlapping lesion of biliary tract,Unknown,Not Reported",,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161035&version=1.0,
Tumor Grade,"Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","G1, G2, G3, G4, GX, GB, High Grade, Low Grade, Unknown, Not Reported, Not Applicable",,,TRUE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2785839&version=2.0,
AJCC Clinical M,"Extent of the distant metastasis for the cancer based on evidence obtained from clinical
 assessment parameters determined prior to treatment.","M0, M1, M1a, M1b, M1c, MX, cM0 (i+), Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3440331&version=1.0,
AJCC Clinical N,"Extent of the regional lymph node involvement for the cancer based on evidence obtained from
 clinical assessment parameters determined prior to treatment.","N0, N0 (i+), N0 (i-), N0 (mol+), N0 (mol-), N1, N1a, N1b, N1bI, N1bII, N1bIII, N1bIV, N1c, N1mi, N2, N2a, N2b, N2c, N3, N3a, N3b, N3c, N4, NX, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3440330&version=1.0,
AJCC Clinical Stage,"Stage group determined from clinical information on the tumor (T), regional node (N) and
 metastases (M) and by grouping cases with similar prognosis for cancer.","Stage 0, Stage 0a, Stage 0is, Stage I, Stage IA, Stage IA1, Stage IA2, Stage IB, Stage IB1, Stage IB2, Stage IC, Stage II, Stage IIA, Stage IIA1, Stage IIA2, Stage IIB, Stage IIC, Stage IIC1, Stage III, Stage IIIA, Stage IIIB, Stage IIIC, Stage IIIC1, Stage IIIC2, Stage IS, Stage IV, Stage IVA, Stage IVB, Stage IVC, Stage Tis, Stage X, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3440332&version=1.0,
AJCC Clinical T,"Extent of the primary cancer based on evidence obtained from clinical assessment parameters
 determined prior to treatment.","T0, T1, T1a, T1a1, T1a2, T1b, T1b1, T1b2, T1c, T1mi, T2, T2a, T2a1, T2a2, T2b, T2c, T2d, T3, T3a, T3b, T3c, T3d, T4, T4a, T4b, T4c, T4d, T4e, TX, Ta, Tis, Tis (DCIS), Tis (LCIS), Tis (Paget's), Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3440328&version=1.0,
AJCC Pathologic M,"Code to represent the defined absence or presence of distant spread or metastases (M) to
 locations via vascular channels or lymphatics beyond the regional lymph nodes, using
 criteria established by the American Joint Committee on Cancer (AJCC).","M0, M1, M1a, M1b, M1c, MX, cM0 (i+), Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3045439&version=1.0,
AJCC Pathologic N,"The codes that represent the stage of cancer based on the nodes present (N stage) according
 to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","N0, N0 (i+), N0 (i-), N0 (mol+), N0 (mol-), N1, N1a, N1b, N1bI, N1bII, N1bIII, N1bIV, N1c, N1mi, N2, N2a, N2b, N2c, N3, N3a, N3b, N3c, N4, NX, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3203106&version=1.0,
AJCC Pathologic Stage,"The extent of a cancer, especially whether the disease has spread from the original site to
 other parts of the body based on AJCC staging criteria.","Stage 0, Stage 0a, Stage 0is, Stage I, Stage IA, Stage IA1, Stage IA2, Stage IB, Stage IB1, Stage IB2, Stage IC, Stage II, Stage IIA, Stage IIA1, Stage IIA2, Stage IIB, Stage IIC, Stage IIC1, Stage III, Stage IIIA, Stage IIIB, Stage IIIC, Stage IIIC1, Stage IIIC2, Stage IS, Stage IV, Stage IVA, Stage IVB, Stage IVC, Stage Tis, Stage X, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3203222&version=1.0,
AJCC Pathologic T,"Code of pathological T (primary tumor) to define the size or contiguous extension of the
 primary tumor (T), using staging criteria from the American Joint Committee on Cancer
 (AJCC).","T0, T1, T1a, T1a1, T1a2, T1b, T1b1, T1b2, T1c, T1mi, T2, T2a, T2a1, T2a2, T2b, T2c, T2d, T3, T3a, T3b, T3c, T3d, T4, T4a, T4b, T4c, T4d, T4e, TX, Ta, Tis, Tis (DCIS), Tis (LCIS), Tis (Paget's), Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3045435&version=1.0,
AJCC Staging System Edition,"The text term used to describe the version or edition of the American Joint Committee on Cancer
 Staging Handbooks, a publication by the group formed for the purpose of developing a system of
 staging for cancer that is acceptable to the American medical profession and is compatible with
 other accepted classifications.","1st, 2nd, 3rd, 4th, 5th, 6th, 7th, 8th, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2722309&version=1.0,
Anaplasia Present,"Yes/no/unknown/not reported indicator used to describe whether anaplasia was present at the
time of diagnosis.","Yes - Anaplasia Present, No, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6059599&version=1.0,
Yes - Anaplasia Present,Indicates anaplasia is present,,Anaplasia Present Type,,FALSE,Diagnosis,,,
Anaplasia Present Type,"The text term used to describe the morphologic findings indicating the presence of a malignant
 cellular infiltrate characterized by the presence of large pleomorphic cells, necrosis, and
 high mitotic activity in a tissue sample.","Absent, Diffuse, Equivocal, Focal, Present, Sclerosis, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=4925534&version=1.0,
Best Overall Response,The best improvement achieved throughout the entire course of protocol treatment.,"AJ-Adjuvant Therapy, CPD-Clinical Progression, CR-Complete Response, CRU-Complete Response Unconfirmed, DU-Disease Unchanged, IMR-Immunoresponse, IPD-Immunoprogression, MR-Minimal/Marginal Response, MX-Mixed Response, Non-CR/Non-PD-Non-CR/Non-PD, NPB-No Palliative Benefit, NR-No Response, PA-Palliative Therapy, PB-Palliative Benefit, PD-Progressive Disease, PPD-Pseudoprogression, PR-Partial Response, PSR-Pseudoresponse, RD-Responsive Disease, RP-Response, RPD-Radiographic Progressive Disease, sCR-Stringent Complete Response, SD-Stable Disease, SPD-Surgical Progression, TE-Too Early, VGPR-Very Good Partial Response",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2003324&version=4.0,
Breslow Thickness,"The number that describes the distance, in millimeters, between the upper layer of the epidermis
and the deepest point of tumor penetration.",,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=64809&version=3.0,
Classification of Tumor,"Text that describes the kind of disease present in the tumor specimen as related to a specific
 timepoint.","Primary, Metastasis, Recurrence, Other, Unknown, Not reported, Not Allowed To Collect",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3288124&version=1.0,
Days to Diagnosis,"Number of days between the date used for index and the date the patient was diagnosed with the
 malignant disease.",,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6154733&version=1.0,
First Symptom Prior to Diagnosis,Text term used to describe the patient's first symptom experienced prior to diagnosis and thought to be related to the disease.,"Altered Mental Status, Headaches, Motor or Movement Changes, Seizures, Sensory Changes, Visual Changes, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6133605&version=1.0,
Gross Tumor Weight,"Numeric value used to describe the gross pathologic tumor weight, measured in grams.",,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6133606&version=1.0,
Laterality,"For tumors in paired organs, designates the side on which the cancer originates.","Bilateral, Left, Midline, Right, Unilateral, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=827&version=3.0,
Lymph Nodes Positive,The number of lymph nodes involved with disease as determined by pathologic examination.,,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=89&version=3.0,
Lymph Nodes Tested,The number of lymph nodes tested to determine whether lymph nodes were involved with disease as determined by a pathologic examination.,,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3&version=3.0,
Lymphatic Invasion Present,"A yes/no indicator to ask if small or thin-walled vessel invasion is present, indicating lymphatic involvement","Yes, No, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=64171&version=3.0,
Metastasis at Diagnosis,The text term used to describe the extent of metastatic disease present at diagnosis.,"Distant Metastasis, Metastasis NOS, No Metastasis, Regional Metastasis, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6133614&version=1.0,
Metastasis at Diagnosis Site,Text term to identify an anatomic site in which metastatic disease involvement is found.,"Abdomen, Adrenal Gland, Ascites, Bone, Bone Marrow, Brain, Cerebrospinal Fluid, Central Nervous System, Colon, Distant Nodes, Distant Organ, Groin, Kidney, Liver,  Lung, Lymph Node, Axillary, Lymph Node, Inguinal, Lymph Node NOS, Mediastinum,  Omentum, Ovary, Pelvis, Peritoneal Cavity,  Peritoneum,  Pleura, Scalp, Skin, Small Intestine, Soft Tissue, Spinal Cord, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3029815&version=1.0,
Method of Diagnosis,Text term used to describe the method used to confirm the patients malignant diagnosis.,"Autopsy,Biopsy,Blood Draw,Bone Marrow Aspirate,Core Biopsy,Cytology,Cystoscopy,Debulking,Diagnostic Imaging,Dilation and Curettage Procedure,Enucleation,Excisional Biopsy,Fine Needle Aspiration,Imaging,Incisional Biopsy,Laparoscopy,Laparotomy,Other,Pap Smear,Physical Exam,Pathologic Review,Surgical Resection,Thoracentesis,Ultrasound Guided Biopsy,Unknown,Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6161031&version=1.0,
Mitotic Count,"The number of mitoses identified under the microscope in tumors. The method of counting varies, according to the specific tumor examined. Usually, the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.",,,,FALSE,Diagnosis,,,
Percent Tumor Invasion,The percentage of tumor cells spread locally in a malignant neoplasm through infiltration or destruction of adjacent tissue.,,,,FALSE,Diagnosis,,,
Peritoneal Fluid Cytological Status,The text term used to describe the malignant status of the peritoneal fluid determined by cytologic testing.,"Atypical, Malignant, Non-Malignant, Unsatisfactory, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6690681&version=1.0,
Perineural Invasion Present,A yes/no indicator to ask if perineural invasion or infiltration of tumor or cancer is present.,"Yes, No, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=64181&version=3.0,
Residual Disease,Text terms to describe the status of a tissue margin following surgical resection.,"R0, R1, R2, RX, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2608702&version=1.0,
Synchronous Malignancy,"A yes/no/unknown indicator used to describe whether the patient had an additional malignant diagnosis at the same time the tumor used for sequencing was diagnosed. If both tumors were sequenced, both tumors would have synchronous malignancies.","Yes, No, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6142390&version=1.0,
Tumor Confined to Organ of Origin,The yes/no/unknown indicator used to describe whether the tumor is confined to the organ where it originated and did not spread to a proximal or distant location within the body.,"Yes, No, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=4925494&version=1.0,
Tumor Focality,The text term used to describe whether the patient's disease originated in a single location or multiple locations.,"Multifocal, Unifocal, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3174022&version=1.0,
Tumor Largest Dimension Diameter,"Numeric value used to describe the maximum diameter or dimension of the primary tumor, measured in centimeters.",,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=64215&version=3.0,
Vascular Invasion Present,The yes/no indicator to ask if large vessel or venous invasion was detected by surgery or presence in a tumor specimen.,"Yes - Vascular Invasion Present, No, Unknown, Not Reported, Not Allowed To Collect",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=64358&version=3.0,
Yes - Vascular Invasion Present,Indicates venous invasion was detected by surgery or presence in a tumor specimen,,Vascular Invasion Type,,FALSE,Diagnosis,,,
Vascular Invasion Type,Text term that represents the type of vascular tumor invasion.,"Extramural, Intramural, Macro, Micro, No Vascular Invasion, Unknown, Not Reported",,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3168001&version=1.0,
Year of Diagnosis,Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.,,,,FALSE,Diagnosis,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2896960&version=1.0,
Biospecimen Type,Biospecimen Type,"Tissue Biospecimen Type, Blood Biospecimen Type, Analyte Biospecimen Type, Mouth Rinse Biospecimen Type, Stool Biospecimen Type, Urine Biospecimen Type, Ascites Biospecimen Type, Sputum Biospecimen Type, Fluids Biospecimen Type, Bone Marrow Biospecimen Type, Cells Biospecimen Type",,,TRUE,Biospecimen,,,
Analyte Biospecimen Type,A molecular derivative (I.e. RNA / DNA / Protein Lysate) obtained from a specimen,,"Analyte Type, Fixation Duration, Slide Type, Slide Thickness Value, Sectioning Days from Index, Shipping Condition Type, Ischemic Time, Ischemic Temperature",,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2513915&version=2.0,
Tissue Biospecimen Type,Tissue biospecimen,,"Ischemic Time, Ischemic Temperature, Site of Resection or Biopsy, Specimen Laterality, Portion Weight, Total Volume, Tumor Tissue Type, Histologic Morphology Code, Preservation Method",,FALSE,Biospecimen,,,
Bone Marrow Biospecimen Type,Bone Marrow biospecimen,,"Ischemic Time, Ischemic Temperature, Site of Resection or Biopsy, Specimen Laterality, Portion Weight, Total Volume, Tumor Tissue Type, Histologic Morphology Code, Preservation Method",,FALSE,Biospecimen,,,
Urine Biospecimen Type,Urine biospecimen,,"Ischemic Time, Ischemic Temperature, Site of Resection or Biopsy, Specimen Laterality, Portion Weight, Total Volume, Tumor Tissue Type, Histologic Morphology Code, Preservation Method",,FALSE,Biospecimen,,,
Blood Biospecimen Type,Blood biospecimen,,Shipping Condition Type,,FALSE,Biospecimen,,,
Timepoint Label,Label to identify the time point at which the biospecimen was obtained. NO PHI/PII INFORMATION IS ALLOWED.,"Baseline, End of Treatment, Overall survival, Final",,,TRUE,Biospecimen,,,
Collection Days from Index,Number of days from the research participant's index date that the biospecimen was obtained.,,,,TRUE,Biospecimen,,,
Protocol ID,"Identifier that describes the protocol by which the sample was obtained or generated. It must be a valid Digital Object Identifier (DOI), e.g. pointing to Protocols.io. This includes protocols for collection as well as processing depending on the sample ie- dissociation.",,,,TRUE,Information Content Entity,,,
Adjacent Biospecimen ID,"List of HTAN Identifiers (separated by commas) of adjacent biospecimens cut from the same sample; for example HTA3_3000_3, HTA3_3000_4, ...",,,,TRUE,Biospecimen,,,
Analyte Type,The kind of molecular specimen analyte: a molecular derivative (I.e. RNA / DNA / Protein Lysate) obtained from a specimen,"cfDNA Analyte, DNA Analyte, RNA Analyte, Total RNA Analyte, Tissue Block Analyte, Tissue Section Analyte, PBMCs or Plasma or Serum Analyte, cDNA Libraries Analyte",,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2513915&version=2.0,
Acquisition Method Type,Records the method of acquisition or source for the specimen under consideration.,"Autopsy, Biopsy, Fine Needle Aspirate, Surgical Resection, Punch Biopsy, Shave Biopsy, Excision, Re-excision, Sentinel Node Biopsy, Lymphadenectomy - Regional Nodes, Other Acquisition Method,  Not specified",,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=6626651&version=1.0,
Other Acquisition Method,A custom acquisition method,,Acquisition Method Other Specify,,FALSE,Biospecimen,,,
Acquisition Method Other Specify,A custom acquisition method [Text - max length 100 characters],,,,TRUE,Biospecimen,,,
Preservation Method,Text term that represents the method used to preserve the sample.,"Cryopreserved, Cryopreservation in liquid nitrogen - dead tissue, Cryopreservation in dry ice - dead tissue, Cryopreservation in liquid nitrogen - live cells, Formalin fixed paraffin embedded - FFPE, Formalin fixed-unbuffered, Formalin fixed-buffered, Fresh, OCT, Snap Frozen, Frozen, Negative 80 Deg C, Liquid Nitrogen, Fresh dissociated, Fresh dissociated and single cell sorted, Fresh dissociated and single cell sorted into plates, Methacarn fixed paraffin embedded - MFPE, Unknown, Not Reported",,,TRUE,Biospecimen,,,
Fixative Type,Text term to identify the type of fixative used to preserve a tissue specimen,"Acetone, Alcohol, Formalin, Glutaraldehyde, OCT media, RNAlater, Saline, 95% Ethanol, Dimidoester, Carbodiimide, Dimethylacetamide, Para-benzoquinone, PAXgene tissue, TCL lysis buffer, NP40 lysis buffer, Methacarn, Cryo-store, Other, None, Unknown",,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=65078&version=3.0,
Fixation Duration,"The length of time, from beginning to end, required to process or preserve biospecimens in fixative (measured in minutes)",,,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5230144&version=1.0,
Ischemic Time,"Duration of time, in seconds, between when the specimen stopped receiving oxygen and when it was preserved or processed. Integer value.",,,,FALSE,Biospecimen,,https://data.humancellatlas.org/metadata/dictionary/biomaterial/specimen_from_organism#specimen_from_organism-state_of_specimen-gross_description,
Ischemic Temperature,Specify whether specimen experienced warm or cold ischemia.,"Warm Ischemia, Cold Ischemia, Ambient air, 4C wet ice, Negative -20 Deg C Dry Ice, Liquid Nitrogen",,,FALSE,Biospecimen,,https://data.humancellatlas.org/metadata/dictionary/biomaterial/specimen_from_organism#specimen_from_organism-state_of_specimen-gross_description,
Collection Media,Material Specimen is collected into post procedure,"DMEM, DMEM+Serum, RPMI, RPMI+Serum, PBS, PBS+Serum",,,FALSE,Biospecimen,,,
Specimen Laterality,"For tumors in paired organs, designates the side on which the specimen was obtained.","Bilateral, Left, Right, Unknown, Not Reported, Not Applicable",,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2007875&version=1.0,
Portion Weight,"Numeric value that represents the sample portion weight, measured in milligrams.",,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5432593&version=1.0,
Total Volume,"Numeric value for the total amount of sample or specimen, measured in milliliters (mL).",,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3005019&version=1.0,
Tumor Tissue Type,Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint.,"Additional Primary, Local recurrence, Metastatic, Premalignant, Primary, Recurrent, Not Otherwise Specified, Premalignant - in situ, Atypia - hyperplasia",,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3288124&version=1.0,
Histologic Morphology Code,"Histologic Morphology Code, based on ICD-O-3. Any valid ICD-O-3 morphology code. See https://seer.cancer.gov/icd-o-3/ and https://seer.cancer.gov/icd-o-3/sitetype.icdo3.20200629.xlsx. Examples: 80510",,,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3226275&version=1.0,
Preinvasive Morphology,"Histologic Morphology not included in ICD-O-3 morphology codes, for preinvasive lesions included in the HTAN","Melanocytic hyperplasia, Atypical melanocytic proliferation, Melanoma in situ - superficial spreading, Melanoma in situ - lentigo maligna type, Melanoma in situ - acral-lentiginous, Melanoma in situ - arising in a giant congenital nevus, Persistent melanoma in situ, Melanoma in situ - not otherwise classified, Scar - no residual melanoma, Invasive melanoma - superficial spreading, Invasive melanoma - nodular type, Invasive melanoma - lentigo maligna, Invasive melanoma - acral lentiginous, Invasive melanoma - desmoplastic, Invasive melanoma - nevoid, Invasive melanoma - other",,,FALSE,Biospecimen,,,
Slide Type,A description of the charge on the glass slide.,"Uncharged, Charged, Coverslip, Not applicable, Other",,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5227611&version=1.0,
Slide Thickness Value,"Numeric value to describe the thickness of a slice to tissue taken from a biospecimen, measured in microns (um).",,,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=3024951&version=1.0,
Sectioning Days from Index,Number of days from the research participant's index date that the biospecimen was sectioned after collection,,,,TRUE,Biospecimen,,,
Storage Method,The method by which a biomaterial was stored after preservation or before another protocol was used.,"Ambient temperature, Cut slide, Fresh, Frozen at -70C, Frozen at -80C, Frozen at -150C, Frozen in liquid nitrogen, Frozen in vapor phase, Raraffin block, RNAlater at 4C, RNAlater at 25C, RNAlater at -20C, Refrigerated at 4 degrees, Refrigerated vacuum chamber, Unknown",,,TRUE,Biospecimen,,https://data.humancellatlas.org/metadata/dictionary/biomaterial/specimen_from_organism#specimen_from_organism-preservation_storage-storage_method,
Processing Days from Index,Number of days from the research participant's index date that the biospecimen was processed,,,,TRUE,Biospecimen,,,
Shipping Condition Type,Text descriptor of the shipping environment of a biospecimen.,"Ambient Pack, Cold Pack, Dry Ice, Ice Pack, Liquid Nitrogen, Other Shipping Environment, Specimen at Room Temperature",,,TRUE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5495533&version=1.0,
Site Data Source,"Text to identify the data source for the specimen/sample from within the HTAN center, if applicable. Any identifier used within the center to identify data sources. No PHI/PII is allowed.",,,,FALSE,Biospecimen,,,
Processing Location,"Site with an HTAN center where specimen processing occurs, if applicable. Any identifier used within the center to identify processing location. No PHI/PII is allowed.",,,,FALSE,Biospecimen,,,
Histology Assessment By,Text term describing who (in what role) made the histological assessments of the sample,"Pathologist, Research Scientist, Other, Unknown",,,FALSE,Biospecimen,,,
Histology Assessment Medium,The method of assessment used to characterize histology,"Digital, Microscope, Other, Unknown",,,FALSE,Biospecimen,,,
Tumor Infiltrating Lymphocites,Measure of Tumor-Infiltrating Lymphocytes [Number],,,,FALSE,Biospecimen,,,
Degree of Dysplasia,Information related to the presence of cells that look abnormal under a microscope but are not cancer. Records the degree of dysplasia for the cyst or lesion under consideration.,"Normal or basal cell hyperplasia or metaplasia, Mild dysplasia, Moderate dysplasia, Severe dysplasia, Carcinoma in Situ, Unknown",,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5543188&version=1.0,
Dysplasia Fraction,Resulting value to represent the number of pieces of dysplasia divided by the total number of pieces. [Text: max length 5],,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2390593&version=1.0,
Number Proliferating Cells,Numeric value that represents the count of proliferating cells determined during pathologic review of the sample slide(s).,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5432636&version=1.0,
Percent Eosinophil Infiltration,Numeric value to represent the percentage of infiltration by eosinophils in a tumor sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2897700&version=2.0,
Percent Granulocyte Infiltration,Numeric value to represent the percentage of infiltration by granulocytes in a tumor sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2897705&version=2.0,
Percent Inflam Infiltration,"Numeric value to represent local response to cellular injury, marked by capillary dilatation, edema and leukocyte infiltration; clinically, inflammation is manifest by redness, heat, pain, swelling and loss of function, with the need to heal damaged tissue.",,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2897695&version=1.0,
Percent Lymphocyte Infiltration,Numeric value to represent the percentage of infiltration by lymphocytes in a solid tissue normal sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2897710&version=2.0,
Percent Monocyte Infiltration,Numeric value to represent the percentage of monocyte infiltration in a sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5455535&version=1.0,
Percent Necrosis,Numeric value to represent the percentage of cell death in a malignant tumor sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2841237&version=1.0,
Percent Neutrophil Infiltration,Numeric value to represent the percentage of infiltration by neutrophils in a tumor sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2841233&version=1.0,
Percent Normal Cells,Numeric value to represent the percentage of normal cell content in a malignant tumor sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2841233&version=1.0,
Percent Stromal Cells,"Numeric value to represent the percentage of reactive cells that are present in a malignant tumor sample or specimen but are not malignant such as fibroblasts, vascular structures, etc.",,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2841241&version=1.0,
Percent Tumor Cells,Numeric value that represents the percentage of infiltration by tumor cells in a sample.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=5432686&version=1.0,
Percent Tumor Nuclei,Numeric value to represent the percentage of tumor nuclei in a malignant neoplasm sample or specimen.,,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=2841225&version=1.0,
Fiducial Marker,Imaging specific: fiducial markers for the alignment of images taken across multiple rounds of imaging.,"Beads, Sterile placement needles, Suture type markers, Gold fiducial markers, Titanium screws, Adhesive markers, Other, Unknown, Not Reported",,,FALSE,Biospecimen,,https://data.humancellatlas.org/metadata/dictionary/protocol/imaging/imaging_preparation_protocol#imaging_preparation_protocol-protocol_core-protocols_io_doi,
Slicing Method,Imaging specific: the method by which the tissue was sliced.,"Vibratome, Cryosectioning, Tissue molds, Sliding microtome, Sectioning, Other, Unknown, Not Reported",,,FALSE,Biospecimen,,https://data.humancellatlas.org/metadata/dictionary/protocol/imaging/imaging_preparation_protocol#imaging_preparation_protocol-protocol_core-protocols_io_doi,
Antigen Retrieval ,"Imaging specific: information on antigen retrieval when it is used for a pathology specimen. E.g. pH 6 (Citric Acid), pH 8 (tris), or pH 10. [Text - max length 100] ",,,,FALSE,Biospecimen,,https://cdebrowser.nci.nih.gov/cdebrowserClient/cdeBrowser.html#/search?publicId=64676&version=3.0,
Biospecimen Slide Location,Imaging specific: text term to capture the relative position and orientation of the core location within a piece of tissue on the slide relative to the region of interest slide coordinates. use https://docs.openmicroscopy.org/ome-model/6.0.1/developers/roi.html#shape-concrete-implementations if applciable,,,,FALSE,Biospecimen,,,
Staining Markers,Imaging specific: text to identify proteins/ antibodies selected for staining,,,,FALSE,Biospecimen,,,
Lysis Buffer,scRNA-seq specific: Type of lysis buffer used,,,,FALSE,Biospecimen,,,
Method of Nucleic Acid Isolation,"Bulk RNA & DNA-seq specific: method used for nucleic acid isolation. E.g. Qiagen Allprep, Qiagen miRNAeasy. [Text - max length 100]",,,,FALSE,Biospecimen,,,
